UROS appoints Gerrit Jan Konijnenberg as CEO to speed-up affordable global roaming

UROS (http://uros.com/?utm_source=press_release&utm_medium=cision&utm_campaign=Konijnenberg_CEO), the provider of low-cost global data roaming solutions, today announces the appointment of Gerrit Jan Konijnenberg as the new Group Chief Executive Officer. Gerrit Jan Konijnenberg joins UROS from a Senior Vice President position at Vodafone starting from 1st of September 2015. The new CEO has a long history of success in telecoms and media marketing, sales and general management which is expected to strengthen UROS’ role in providing low-cost global roaming solutions to mobile network operators. UROS, Uni-fi Roaming Solutions, was established 4 years ago with the vision to help international travellers combat excessive roaming charges. Now bill-shock free roaming is provided globally via the Goodspeed 4G mobile hotspot (https://goodspeed.io/?utm_source=press_release&utm_medium=cision&utm_campaign=Konijnenberg_CEO) using UROS’ patented technology. The Goodspeed mobile hotspots are steered and monitored via the company’s global M2M platform and can carry multiple SIM cards, which can connect up to 15 devices via Wi-Fi to secure mobile networks around the world. Currently corporates can purchase the solution directly from UROS or from the official Goodspeed distributors. The new CEO however sees mobile operators as the next opportunity for growth. Konijnenberg explains: ”The amount of unconnected devices of travellers is growing, as well as their appetite for large data bundles. But there are many silent roamers who are not connected to a mobile network due to the fear of bill-shock or lack of connection availability. Via its propriety technology UROS enables Mobile Network Operators and MVNO’s to offer large daily bundles at low cost around the globe – a service that they often cannot offer themselves, due to complex and many times slow, billing record between the roaming and home networks. The latest version of the Goodspeed mobile hotspot has been launched in collaboration with ZTE this summer. With the new device, a 4G roaming experience is delivered to customers even without any 4G roaming capabilities needed from the mobile operators or MVNO’s in their home network!” UROS founders Jyrki Hallikainen and Tommi Uhari are excited to see Gerrit Jan Konijnenberg join UROS: ”We’ve been looking for an international carrier executive who can help accelerate the company’s growth. We’re excited to have Gerrit Jan join the team and lead the company in its further global expansion with mobile network operators.” Tommi Uhari, who has been leading UROS as CEO until now, will continue as a company board member together with Chairman Jyrki Hallikainen. 

DIY Projects to Create the Perfect Thanksgiving

Give your audience something else to be thankful for this year by sharing inspiration and tools to create handmade Thanksgiving decor. Fiskars has the products and ideas to make festive Thanksgiving décor easily. Many of the projects are so simple kids can help, too, providing more opportunities for memory making.Intricate Shape Punches – These punches are available in a variety of designs and are great for creating detailed shapes that can be used as embellishments. They are designed to require less force per punch and reduce paper jams for frustration-free cutting. Tag Maker with Built-in Eyelet Setter – The Tag Maker features an innovative design that makes it easy to create tags complete with set eyelets in three quick, simple steps.RazorEdge™ Micro-Tip® Easy Action™ Shears (6") – Ideal for cutting in tight spaces and making detailed cuts through materials like silk, light leather, polyester and felt.ProCision™ Rotary Bypass Trimmer – Ideal for making straight, precise cuts through multiple sheets of cardstock and chipboard in addition to more traditional crafting materials. For step-by-step ideas to share with your audience, check out the articles below on Fiskars.com: Kids Thanksgiving Table DecorationsThanksgiving Table DecorationsTurkey Leg Place Card and Other Kids Table DecorThanksgiving Turkey T-shirtStuffed Turkey Kids CraftThanksgiving Burlap Grateful BannerThanksgiving Cooking with Kitchen Shears

Student Sit-in Leads to Open Dialogue and Shared Learning Experience

We are proud of our students who brought their concerns to the Towson University administration. We applaud them for their conviction and their passion. Last evening’s exchange of ideas was a mutual learning experience that resulted in a shared vision and a feasible course of action. In the words of the students themselves, the opportunity for discourse was as important as their list of requests. We feel confident that we can move forward with the agreement that Interim President Chandler signed last night, and we look forward to continued dialogue to make our campus a welcoming and productive environment for every student.   “This is what universities are supposed to do. We are supposed to help students express their opinions and find solutions to problems. I'm extraordinarily proud of this group of students, who want to make this a better place, not just for them, but for all of us." Interim President Timothy Chandler   The Request of the Black Students at Towson University   We, the black students of Towson University, come with burdened bodies to your door steps. We come as living testament to the narratives shared on November 11th, where with tears and rage, we stood together and publicly revealed the oppressive occurrences that we experience on the daily as black students of this institution. Among these have included: egg shells and racial slurs being thrown out of windows; racial slurs being shouted at house parties; sexual and racial epithets from classroom professors; lack of representation in black faculty on the tenure track; lack of cultural competency in our peers and professors; the discontinuation of the Towson Debate Team; etc, etc. We are gathered here today to make known and make clear that Towson University has failed at providing a safe space for the black students at this University. We are gathered today to work with the administration, whose checks are signed with the money from our tuition, towards a more critical, honest, and inclusive campus for all Towson University Students. We are gathered here today to request sincere and swift institutional changes.               Among these are: 1. Increasing the tenured and tenure-track black faculty and retaining them by 10% by 2018. Fall 2018     2. Require the President to work with the Provost to ensure that every college or department has one meeting per semester dedicated to CSD cultural competency content           approved by a student representative that works in the CDSO.          Fall 2016      3.  Advocate for IFC Fraternities and Pan-Hellenic Sororities to have a Diversity Chair who will promote diversity within their respective organizations and interact with            multicultural organizations on campus.  .          Spring 2016       4. Send a letter to the President of USM Student Council regarding the review and termination of the contract, vendoring, and purchasing of appliances, tools, furniture             and any other items produced within Maryland State and Federal prisons. Given the status of the prison-industrial complex and the criminalization of black bodies,               along with the school-to-prison pipeline, we find it problematic that we finance the same institution that profit off of black bodies.          Spring 2016       5.  Advocate to require the SGA to maintain communication with the Diverse Organizations and their leaders on campus through physical contact, wherein bills and                    policies that will effect the black student body will be made known and aware to them.             ASAP / Fall 2015       6. Require the President’s Diversity Coordinating Council and other institution-wide diversity committees to have diverse (including multi-cultural) representation on               the committee that reflects the underrepresented cultures of the student body.           Fall 2016       7.  Set an expectation to diversify the representation of the committees determining tenure at Towson and require college deans to report on their efforts and results.                  Such efforts could include but are not limited to: Encourage students to complete course evaluations in course syllabi; Invite student feedback for pending tenure                  cases; Provide the opportunity for faculty tenure candidates to identify an advocate to serve on any level of their choosing in the tenure process.            Fall 2018.       8.  Advocate for the Director Positions in the SGA to be elected by the people of this university instead of appointed, hired, and/or interviewed by the President. The                  Diversity Chair is a direct representative of the minority students and should be elected directly by and for minority students.            Spring 2016       9.  Return the Towson University Debate Team to a traveling debate team as soon as possible and no later than Fall 2016. The Debate Team is an intellectual fixture in              the Towson University black community where black students have been nationally successful and active contributors to bringing justice to black people at this                    institution.             Fall 2016      10.  Honestly and strictly enforce the university’s policies on non-discrimination. Proactively work to create a marketing campaign to educate and communicate our                     Hate/Bias procedures and response.Distribute a public statement on Towson University’s response on those issues when they occur. Publicly. The mental and                       emotional health of this University’s black students across all intersections need to be taken as seriously as their physical health.             ASAP / Fall 2015      11.  Require that policing practices be equitable for black events and white events alike,  .          Spring 2016      12. Advocate for the establishment of a course requirement in American race relations for students by meeting with the necessary and appropriate entities (such as the                  Curriculum Committee, University Senate, MHEC, USM, etc).            Fall 2016   I, hereby certify that I have heard the voices of the black students of Towson University. By signing my signature on the line below, I am promising to: 1) Release a public statement within 24 hours  acknowledging the demands and my sincere effort to commit to actively advocate and implement these concerns. 2) Begin immediately working on continuing communication with the black student body and moving forward in addressing the issues outlined above. By signing my signature on the line below I am acknowledging that in the event that I do not keep my promise and begin to address these concerns, I will resign as president of this University for failing to effectively represent black students. x ___________________________________________________________________________________ (The signed document is available as a PDF. This site does not support the display of PDFs.)

Next year will be a record-breaking year at Helsinki Airport: The most extensive route selection ever

Helsinki Airport was celebrating on Thursday 19 November, as Norwegian commenced daily flights to Dubai. The new route will prepare Helsinki Airport for next year, when new records will again be set. "We are really looking forward to 2016, when Helsinki Airport will have its highest ever number of long-haul flights to Asia, the Middle East and North America. There will be more than one hundred weekly long-haul flights, of which 85 are bound to Asia and 15 to the United States. The expansion in the route selection is an example of our airport's important role as the hub of Northern Europe's Asian flights, and as an effective transit airport", says Ville Haapasaari, director of Helsinki Airport. In 2016, the total number of Asian destinations will be as much as 17. In the summer season, the airport will have new Finnair routes to Guangzhou in China and to Fukuoka in Japan. Next summer, Helsinki Airport will be the largest airport in Europe in regard to the number of routes to Japan: Helsinki will offer routes to Tokyo, Osaka, Nagoya and Fukuoka. In regard to the number of all Asian flights, Helsinki Airport is the fifth largest airport in Europe. Total of 21 long-haul routes from Helsinki Airport in 2016 Asia: Bangkok, Chongqing, Delhi, Fukuoka (new in 2016), Guangzhou (new in 2016), Ho Chi Minh City, Hong Kong, Nagoya, Krabi, Osaka, Peking, Phuket, Seoul, Shanghai, Singapore, Tokyo, Xian Middle East: Dubai North America Miami, New York, Chicago In addition to regular direct flights, Helsinki Airport has charter flights to long-haul destinations. New airline commences flights at Helsinki Airport Czech Airlines will again operate at Helsinki Airport. The airline will commence flights between Helsinki Airport and Prague in March 2016. "Czech Airlines will return to Helsinki Airport after a break of a few years. We are very happy that we will get more connections to European destinations, too. Other companies will also provide more flights to Europe", says Haapasaari. Selected Helsinki Airport flight route news Norwegian will commence daily flights from Helsinki Airport to Dubai on 19 November. Dubai is a popular winter destination, and it is evident why that is the case: the sun is shining and the time difference is only two hours. Norwegian's flights to Dubai will depart daily from Helsinki Airport at 5:55 pm and arrive back in Helsinki is at 8:55 am. Finnair will also provide flights to Dubai six times per week in the winter season. For the summer period 2016, Finnair will offer flights to Fukuoka in Japan and Guangzhou in China. Flights to Fukuoka in southern Japan will operate three times a week in the summer of 2016. Flights from Helsinki to Guangzhou will be provided four times per week. Miami will be a new summer destination for Finnair in April 2016, after which Finnair will provide the Miami route all year round three times per week: on Mondays, Thursdays and Sundays. Chicago will continue to be Finnair's summer destination in 2016, and flights will operate from Helsinki Airport five times a week: on Mondays, Thursdays, Fridays, Saturdays and Sundays. After a five-year break, Czech Airlines will commence flights from Helsinki Airport to Prague. As of April, the route will be provided every day. Finnair will become the first airline to introduce an international connection to Longyearbyen in Svalbard in the Norwegian Arctic. The connection to this archipelago destination in the northern Arctic Ocean will be provided from June to August, three times a week. Finnair will introduce three weekly flights to Edinburgh in the summer. In addition, Finnair will commence daily flights to Billund in Denmark, which will operate all year round. Finnair will also commence flights to Pula, located by the Adriatic Sea in Croatia, twice a week in high summer. The year 2020 is the aim of Finavia’s development programme The objective of Finavia's EUR 900 million development programme is to strengthen the position of Helsinki Airport among international airports and as an important hub between Europe and Asia. As a result of the expansion, Helsinki Airport will be capable of serving 20 million passengers in 2020.

Lapland Airports: Large development project completed - Renewed terminal introduced in Ivalo

As a result of the expansion and renewal, the passenger experience at Ivalo Airport has been taken to a higher level. In addition to the new, modern expansion wing, the old terminal building has been completely renovated. Finavia repaved the air traffic areas last year and has also improved the airport parking areas. "Finavia's €13.5 million investment at Ivalo Airport is the largest single input in network airport development in the last few years, and as the work is now complete, we are very happy. By making Lapland airports more effective and smooth, we have also otherwise invested extensively in Lapland tourism, and in that way, we are promoting the operating preconditions of the region's tourism operators", says Joni Sundelin, director at Finavia. The design of the renovated terminal pays particular attention to passenger waiting rooms and restaurant services. The gate area shop has local food products available for sale, such as berry products, fish and meat. In the pre-security check area, there is a new café that serves everyone at the airport. The café also offers souvenirs and local handicrafts. The focus in regard to terminal furniture and lights is on Finnish products and quality. Part of the terminal still includes a segment of wooden wall and a fireplace. The terminal expansion wing was introduced in May; the wing has fully renovated check-in facilities, security check and baggage handling facilities. After the renovation project is fully completed, the travelling experience will be even smoother and more comfortable, especially during high season. Finavia will also prepare the airport for increasing traffic volumes. In 2015, the main focus has been on the development of the airports in Lapland. The terminal at Rovaniemi was renovated, resulting in a new level of functionality, appearance and comfort. At the recently renovated Kittilä Airport, a renovation of air traffic areas was completed in August.


Selected highlights: · Q3 2015 revenues of USD 4.8 million, up 36% from previous quarter · Organic revenue growth in SaaS segment of 17.5% over previous quarter · Major new contracts signed with Gannett (USA Today), Softbank Group Company ITMedia, Lawson convenience store in Japan, The Weather Channel, Japan Tobacco and Australian broadcaster SBS · Maxifier integration completed with widened product offering and substantial cost reductions · Adjusted Q3 2015 EBITDA of USD -1.6 million, a loss reduction of 0.6 million vs Q2 2015 · The acquisition of Ramp Media in October 2015 strengthens our footprint in North America and extends our offering to the rapidly growing video solutions market, adding clients such as ABC News, FOX Sports, the NFL and the NBA · Successfully raised USD 11.4 million in new equity · Cxense is well positioned in the middle of the personalization trend, and experiences strong demand for its combined software offering from publishers, the bank and finance sector, and branded consumer goods The Q3 2015 report and presentation are attached to this notice. Cxense ASA is presenting its Q3 2015 results on Friday November 20, 2015, at 08:30 am CET.  The presentation will take place in the meeting room Bravo at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway.  A live webcast will be available at: http://webtv.hegnar.no/presentation.php?webcastId=25258480 “Cxense continued to experience significant sales growth in Q3 2015, and combined with tight cost control, the company shrunk the EBITDA loss. It is our clear goal to be profitable in 2016 at the same time as we continue to drive the sales growth. Our position within our defined markets is strong, and we are now developing new verticals to extend our market presence.” Ståle Bjørnstad, CEO, Cxense ASA About Cxense: Cxense enables the world's leading media, e-commerce and consumer brands to take control of their audience data to deliver more engaging and personalized user experiences. Businesses using Cxense's advanced real-time analytics, data management (DMP), advertising, search and personalization technology gain more engaged users, increased digital revenue and higher sales conversions. Cxense is headquartered in Oslo, Norway, with offices worldwide. Customers include Condé Nast, Dow Jones/Wall Street Journal, Gannett, Globo, Grupo Clarin, Singapore Press Holdings, South China Morning Post, AEON, DMM, Rakuten, Naspers, Bonnier, Schibsted, and many more. For more information: www.cxense.com, Twitter: @Cxense. Cxense is listed on the Oslo Stock Exchange with the ticker 'CXENSE.' Investor Relations Contact: Jørgen Loeng Chief Financial Officer Email: jorgen.loeng@cxense.com Mobile: +47 906 60 062

Stena Line appeals the Commission’s decision to allow State aid for the Fehmarn tunnel project to the EU Court

Stena Line is a provider of maritime transport links between mainland Europe and the Scandinavian Peninsula. “Stena Line’s ferry routes to and from Scandinavia between 14 different ports serve the market with frequent, environmentally friendly and safe connections for freight and passengers. We welcome competition but it has to be fair and according to current legislation. This is not the case when it comes to the State aid granted for the construction of a fixed link over the Fehmarn Belt.  The Commission has approved State aid for the Fehmarn fixed link for more than 55 years, thereby allowing the fixed link to distort competition in a market with well-functioning ferry services which meet current demand. Ultimately this is also against the fundamental policy of shifting transport away from the road. All we are asking for is a level playing field,” says Carl-Johan Hagman, CEO Stena Line. Stena Line’s appeal is based on a series of manifest errors in the Commission’s decision regarding issues such as the necessity of the aid, the duration of the aid and the undue distortion which the aid gives rise to, in particular by allowing the Fehmarn fixed link to dramatically reduce prices.    “We have no objections to the construction of the link as such but it has to be done in accordance with the well-founded rules for State Aid – this is not the case and we expect the Court to support us to annul the Commission’s decision. We all have to follow the law to assure a level playing field,” Hagman said. Stena Line challenges the Decision before the Union courts in Luxembourg. 


Reference is made to the announcement by Nickel Mountain Group AB (publ.) ("NMG" or the "Company") on 17 November 2015, regarding the result of the Company's extraordinary general meeting. The conditions for the execution of the private placement of 400,000,000 new shares (the “Private Placement”) are now fullfiled and the new share capital will be registered as soon as practically possible. The Company will send a notice when the share capital related to the Private Placement is registered. The last day of trading in the NMG share inclusive the right to receive subscription rights to participate in the fully underwritten reparatory rights issue of up to 60,000,000 new shares is today, 20 November 2015. Reference is made to the announcement by NMG on 19 November 2015, regarding the changes in the management team. Endre Rangnes, the new Chief Executive Officer, has through his wholly owned company Alpette AS, subscribed and been allocated 12,000,000 new shares in the Private Placement. Johnny Tsolis, the new Head of Strategy and Projects, has through his wholly owned company Latino Invest AS, subscribed and been allocated 9,500,000 new shares in the Private Placement. For and on behalf of Nickel Mountain Group AB Torbjörn Ranta For information, please contact Torbjörn Ranta  Mail: torbjorn.ranta@nickelmountain.se Tel: + 46 8 402 28 00 Cell Phone: +46 708 855504 Cautionary Statement: Statements and assumptions made in this document with respect to Nickel Mountain Group AB’s (“NMG”) current plans, estimates, strategies and beliefs, and other statements that are not historical facts, are forward-looking statements about the future performance of NMG. Forward-looking statements include, but are not limited to, those using words such as "may", "might", "seeks", "expects", "anticipates", "estimates", "believes", "projects", "plans", strategy", "forecast" and similar expressions. These statements reflect management's expectations and assumptions in light of currently available information. They are subject to a number of risks and uncertainties, including, but not limited to, (i) changes in the economic, regulatory and political environments in the countries where NMG operates; (ii) changes relating to the geological information available in respect of the various projects undertaken; (iii) NMG’s continued ability to secure enough financing to carry on its operations as a going concern; (iv) the success of its potential joint ventures and alliances, if any; (v) metal prices, particularly as regards nickel. In the light of the many risks and uncertainties surrounding any mineral project at an early stage of its development, the actual results could differ materially from those presented and forecast in this document. NMG assumes no unconditional obligation to immediately update any such statements and/or forecasts.


Financial summary Third quarter 2015 (2014) · Net turnover totalled SEK 111.5 million (617.8 m), of which SEK 69.0 million (516.4 m) comprised royalties for simeprevir, where of SEK 11.5 million referred to past periods.         · Revenues from Medivir’s own pharmaceutical sales totalled SEK 42.6 million (100.8 m), of which SEK 2.8 million (61.6 m) derived from sales of OLYSIO® and SEK 39.8 million (39.2 m) from sales of other pharmaceuticals. · The loss after tax was SEK -10.5 million (373.7 m). · Basic and diluted earnings per share totalled SEK -0.36 (11.95) and SEK -0.36 (11.83), respectively. · The cash flow from operating activities amounted to SEK 75.4 million (473.0 m). Nine months 2015 (2014) · Net turnover totalled SEK 573.2 million (1,390.0 m), of which SEK 387.5 million (1,178.7 m) comprised the first nine months´ royalties for simeprevir. · Revenues from Medivir’s own pharmaceutical sales totalled SEK 184.5 million (210.2 m), of which SEK 50.2 million (83.3 m) derived from sales of OLYSIO® and SEK 134.3 million (126.9 m) from sales of other pharmaceuticals. · The profit after tax was SEK 120.3 million (985.4 m). · Basic and diluted earnings per share totalled SEK 4.14 (31.52) and SEK 4.11 (31.21), respectively. · The cash flow from operating activities amounted to SEK 345.0 million (896.4 m). Summary of the Group’s figures, Q3 Q1-Q3 Full yearcontinuing operations (SEK m) 2015 2014 2015 2014 2014Net turnover 111.5 617.8 573.2 1 390.0 1 767.0Gross profit 90.2 567.6 487.9 1 268.5 1 593.0Operating profit before 1.3 485.7 190.9 1 006.9 1 221.9depreciation and amortisation(EBITDA)Operating profit (EBIT) -13.1 477.3 159.2 982.2 1 188.7Profit/loss before tax -13.3 479.6 155.0 988.3 1 192.7Profit/loss after tax -10.5 373.7 120.3 985.4 1 132.7Operating margin, % -11.8 77.3 27.8 70.7 67.3Basic earnings per share, SEK -0.36 11.95 4.14 31.52 36.24Diluted earnings per share, SEK -0.36 11.83 4.11 31.21 35.90Net worth per share, SEK 55.4 58.8 55.4 58.8 63.4Return on equity -0.9 29.0 8.9 73.4 84.1Cash flow from operating 75.4 473.0 345.0 504.0 1 014.4activitiesLiquid assets and short-term 1 118.1 896.4 1 118.1 896.4 1 395.6investments at the period endR&D spending/total opex, % 68.1 58.6 63.3 59.2 60.8 Conference call for investors, analysts and the mediaThe Interim Report for the third quarter of 2015 will be presented by Medivir’s President & CEO,Niklas Prager and members of Medivir’s management group. Time: Friday, 20 November 2015, at 14.00 (CET). Phone numbers for participants from:Sweden +46 (0)8 566 426 61Europe +44 20 342 814 10USA +1 866 388 1925 The conference call will also be streamed via a link on the website: www.medivir.comThe presentation will be available on Medivir’s website after completion of the conference. CEO’s commentsThe third quarter saw us continuing to build the value of our research portfolio, based on Medivir’s established and documented successful technology platform. Our projects’ progress in Q3 included the launch in July by our partner, Janssen, of a phase I clinical trial of AL-704, a nucleotide-based NS5B polymerase inhibitor from Medivir for the treatment of chronic hepatitis C infection in combination with other direct-acting antivirals. The quarter also marked the launch by Janssen of a phase I clinical trial to evaluate the potential effect of simeprevir and odalasvir on AL-335 pharmacokinetics in healthy volunteers. We were also able to announce, after the quarter end, that Janssen has started a phase IIa clinical trial to evaluate the effect of a triple combination treatment regimen comprising simeprevir, odalasvir and AL-335 in treatment-naïve patients with genotype 1 chronic hepatitis C virus infection. The preclinical safety testing of MIV-711 has been completed and submission of regulatory approval documentation to support this study is underway. Our aim is to start a phase IIa trial at the end of the year. We are engaged in ongoing discussions with potential partners for some time now with regard to the MIV-802 project for the treatment of hepatitis C, and we are now awaiting the results of the ongoing preclinical safety trials before continuing these discussions. These successes in our development projects were very pleasing, but one of our early discovery projects unfortunately failed to live up to expectations. Earlier this year, we launched a partnership with Cancer Research Technology (CRT) for the development of a new class of cancer drugs. Based on data generated during the last six months and after internal reviews of the project, we decided to deprioritise and close down the ADAM8 inhibitor project for pancreatic cancer. In order to continue building long-term value in Medivir as efficiently as possible we have re-sized the commercial organisation during the period, adapting it in line with the declining levels of OLYSIO® sales in the Nordics. We have, accordingly, as of 1st of October, grouped all of our R&D work under the banner of a single, joint unit that will span the entire process, from early discovery to the clinical development phases. I am convinced that not only will this change enhance our ability to prioritise and enhance the efficiency of our research operations; it will also increase our flexibility and ability to broaden the portfolio of projects in clinical development phases. We also, at the same time, created a new function – Strategic Regulatory Affairs – which will house all regulatory skills and areas of responsibility and which is headed by Åsa Holmgren. Åsa has become a member of Medivir’s management group. Royalties attributable to the hepatitis C drug, OLYSIO® (simeprevir), totalled SEK 57.5 million during the third quarter, signalling that the declining trend in net sales of OLYSIO® is continuing, year on year. Our Nordic pharmaceutical sales organisation, comprising Innovative Specialty Care and Nordic Brands, posted combined sales of SEK 42.6 million during the third quarter. OLYSIO® contributed SEK 2.8 million to this total and Nordic Brands posted an increase in sales of 1.3 per cent, year on year. Overall, the quarter has seen the ongoing progress by the majority of our projects enable us to continue building long-term value, despite one set of negative results from our discovery research, and I have every reason to believe that this progress will continue. Niklas PragerPresident and CEO Upcoming reporting dates:Full Year Report 201518 February 2016Interim Report (January – March 2016)28 April 2016Annual General Meeting 20163 May 2016 at 2PM, in Stockholm, Sweden For further information, please contact:Niklas Prager, President & CEO, phone: +46 (0) 8 407 64 30Ola Burmark, CFO, mobile: +46 (0)725-480 580. Medivir is required under the Securities Markets Act to make the information in this press release public.The information was submitted for publication at 08.30 CET on 20 November 2015. About MedivirMedivir is a research based pharmaceutical company with a research focus on infectious diseases and oncology. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Our commercial organization provides a growing portfolio of specialty care pharmaceuticals on the Nordic market. Medivir is listed on the Nasdaq Stockholm Mid Cap List.

New appointments in Boliden's Management Group

Mikael Staffas has been named as business area manager for Boliden Mines and Håkan Gabrielsson as new CFO for the Boliden Group. Both will form part of Boliden's Management Group. Mikael Staffas will take up his new post with immediate effect, whilst maintaining his position as CFO until Håkan Gabrielsson assumes that role. The new appointments mark Boliden's focus on productivity and strong leadership. "During his time as CFO and member of the Group Management, as well as serving as acting Director for Boliden Mines, Mikael Staffas has built up a lot of expertise about the mining business. Håkan Gabrielsson has broad experience of financial management, and since his time as manager for the controller function at Boliden also has extensive knowledge of the Group", says Boliden's CEO Lennart Evrell. Mikael Staffas has been employed by Boliden since 2011. Mikael originally qualified as an academic engineer at KTH, Stockholm, and holds an MBA from INSEAD in France. He previously held the position of CFO at the forestry company Södra and as consultant at McKinsey. Håkan Gabrielsson is a qualified graduate economist from Linköping University, and comes from a position as CFO at the Stockholm Stock Exchange listed company Fagerhult. During the years 2009-2011 Håkan was Director Group Controlling at Boliden, having previously been employed by Electrolux, Ericsson and the aluminium company Sapa.    For further information, please contact:Marcela Sylvander, Group Communications, +46 733 244 551 Boliden is a metals company with a commitment to sustainable development. Our roots are Nordic, but our business is global. The company’s core competence is within the fields of exploration, mining, smelting and metals recycling. Boliden has a total of approximately 4,900 employees and a turnover of SEK 37 billion. Its shares is listed on NASDAQ OMX Stockholm, segment Large Cap.

Ponsse wins Swedish Steel Prize 2015

“Ponsse has not only significantly improved operator ergonomics, but also enhanced functionality and safety, and increased productivity with this new design,” says Gregoire Parenty, chairman of the jury and Executive Vice President and Head of Market Development SSAB.For decades forest harvesting machines have remained pretty much the same. They have traditional designs that focus on function and not on operation. The Finnish company Ponsse decided that by building a new harvester around the operator, with a focus on ergonomic, they could improve both performance and comfort.The Ponsse Scorpion features a symmetrical crane boom where the operator sits in the center point of all movements. If offers the operator total visibility and the ability to work comfortably and efficiently.By using Strenx 700 MC Plus high-strength steel in the crane arms, Strenx 700 in the chassis and Hardox 450 in the cutter head, the Scorpion has a lower overall weight which helps manoeuvrability in rough terrain.Lower weight allowed more bearings to be added, which gives the Scorpion its unique stability. Furthermore, fuel consumption has been reduced and boom movements are faster.The Swedish Steel Prize was awarded for the 17th time in conjunction with a three-day event at which 700 participants from around the world gathered to share the latest findings on high-strength steel.The other finalists, Facil System from Brazil, Milotek from South Africa, and Terex Cranes from Germany, were runners-up in the Swedish Steel Prize 2015.The Swedish Steel Prize was established by SSAB in 1999 to inspire and disseminate knowledge about high-strength steel and how it can be used to develop stronger, lighter and more sustainable products.www.steelprize.comFor further information, please contactMarie Elfstrand, Director Media Relations and PR, tel +46 8 454 57 34Susanne Nordhqwist, Head of Events and Content, tel +46 70 551 83 13For pictures, please visit SSAB’s Media bank (https://imagebank.ssab.com/SSAB/#1448002646752_0)SSAB is a Nordic and US-based steel company. SSAB offers value added products and services developed in close cooperation with its customers to create a stronger, lighter and more sustainable world. SSAB has employees in over 50 countries. SSAB has production facilities in Sweden, Finland and the US. SSAB is listed on the NASDAQ OMX Nordic Exchange in Stockholm and has a secondary listing on the NASDAQ OMX in Helsinki. www.ssab.com.

Rights issue fully underwritten - Resolutions from the Extraordinary General Meeting in Peptonic Medical

Resolution on the Board’s proposal of a rights issue The extraordinary general meeting resolved in accordance with the Board’s proposal of a rights issue on the following terms: Increase the Company’s share capital by a maximum SEK 809 310.80 by a new issue of 8 093 108 shares with preferential rights for shareholders as set out below. 1. Seven (7) existing shares held on the record date entitle to subscribe for six (6) new shares. In the event that not all shares are subscribed for by the exercise of subscription rights, the Board shall decide on allotment of shares without the exercise of subscription rights up to the maximum amount of the rights issue. Such allotment shall be made, firstly, to those who have subscribed for shares by exercising subscription rights and who wish to subscribe for additional shares, pro rata in proportion to their subscription by exercising subscription rights, secondly, to others who have notified their interest to subscribe for shares without exercising subscription rights, pro rata in proportion to their subscription. For practical reasons, when resolving on allotment, the Board may resolve that the above-mentioned allotment will be made of a certain minimum number of shares only. 1. The record date for participation in the rights issue with preferential rights (receipt of subscription rights) shall be November 26, 2015. 1. The subscription price for each new share shall be SEK 2.80. 1. Subscription for new shares shall take place during the period from November 27, 2015, up to and including December 11, 2015, or such later date to be decided by the Board. Subscription for shares by the exercise of subscription rights shall be made by simultaneous cash payment. Subscription for shares without exercising subscription rights shall be made on a separate subscription list and be paid in cash within three (3) business days from the date when notice of allotment by the Board has been sent to the subscriber, or such later date as the Board may decide. All resolutions were adopted unanimously. The rights issue is fully underwritten CEO Johan Inborr announced during his presentation that the rights issue is fully underwritten through subscription undertakings, subscriptions without preferential rights from existing shareholders (19.7 MSEK) and underwriting commitments (3 MSEK). Correction regarding dates of the rights Issue Peptonic Medical announced on November 5 2015, via a press release, that the last day for trading in the shares including right to participate in the Offer is on November 23 2015 and that the first day of trading in the shares excluding right to participate in the Offer is on November 24 2015.  Correct information regarding the above is that the last day for trading in the shares including right to participate in the Offer is on November 24 2015 and that the first day of trading in the shares excluding right to participate in the Offer is on November 25 2015.  For further information, please contact: Johan Inborr, CEO Phone: +46 708 853 893 E-mail: johan.inborr@peptonicmedical.se About Peptonic Medical AB (publ) Peptonic Medical AB (publ) is an innovative Swedish pharmaceutical company developing oxytocin based products e.g. for the treatment of menopausal symptoms, such as vaginal atrophy. Oxytocin has a long history of safe and effective medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. Peptonic Medical AB (publ)’s mission is to develop safe and effective drugs based on oxytocin.

Cloetta considers closing factory in Dieren

Cloetta is active in a highly competitive market and must therefore constantly be cost effective. The acquisition of Lonka creates synergies in administration, sales, procurement and supply chain. Cloetta has evaluated how cost savings can be achieved through the closure of the factory in Dieren, the Netherlands. The factory has 34 employees. It is Cloetta’s intention to close the factory in Dieren at the end of 2016 and transfer production to the factory in Levice, Slovakia. The factory in Levice will be extended as part of the transfer. The transfer will also make it possible to insource additional production to the factory in Levice. The proposed closure of the factory and transfer of production would give rise to one-off costs and capital investments totalling approximately SEK 120m. The bulk of the one-off costs and capital investments will occur in 2016. The closure of the factory in Dieren, insourcing of production and synergies in administration, sales and procurement from the acquisition of Lonka will generate savings of at least SEK 35m on an annual basis. The savings will have a gradual effect in 2016 and in 2017 are expected to contribute to Cloetta’s target of an adjusted EBIT margin of 14 per cent. The full run rate of the savings is expected in 2018. Cloetta will initiate consultations with the local works council and the European Works Council. The information contained in this press release is such that Cloetta is required to disclose pursuant to the Swedish Financial Instruments Trading Act and/or the Swedish Securities Markets Act. The information was submitted for publication on 20 November 2015 at 08:40 a.m. CET.

Senzime expands the company's advisory board and appoints new CTO

Faced with the continued development and strategy issues relating to product and business development as well as commercialization Senzime has expanded its advisory board to include, in addition to Lars Wiklund, Ann-Kristin Berggren, surgical nurse and Tomas Lorant, transplant surgeon. Ann-Kristin Berggren is a registered operating room nurse with experience in the pharmaceutical industry and entrepreneurship. She also has a diploma in Business Administration and now works as an advisor to life-sciences companies. Tomas Lorant is an associate professor in experimental transplant surgery and transplant physician at Uppsala University Hospital. His research concerns transplantation immunology, rejection mechanisms and organ preservation. The research involves both clinical and experimental studies. These new members and their complementary experience in entrepreneurship, diagnostics and surgery will be highly valuable in a number of important areas for the continued development of Senzime. Furthermore, Anders Jacobson is assigned as new CTO. He succeeds Thomas Carlsson, who will retire this spring. Anders background is Biotage Sweden AB, a biotechnology company that provides separation technologies and solutions for analytical chemistry, where he was responsible for instrument development. Previously, Anders VP Technology Development and Supply of Prostalund Sweden AB, a medical technology company that offers products in urology. For further information, please contact:Lena Söderström, CEO of Senzime ABTel: +46 708-16 39 12, email: lena.soderstrom@senzime.com About SenzimeSenzime develops and markets analytical instruments and related disposable products, enabling automated, continuous monitoring of vital substances including glucose (sugar), in biological fluids. Senzime has two platforms for continuously monitoring glucose and lactate – BioSenz in biotech environment and CliniSenz for continuous patient-monitoring. Via microdialysis in tissue or blood Senzime offers a complete system enabling continuous monitoring which is critical to detect post- surgery complications. The company's share is listed on Aktietorget since 2008. www.senzime.com


20 November 2015, Argyll, Scotland -- The Village at Machrihanish Dunes, was honoured to win not one but two coveted Scottish Golf Tourism Awards at Friday night’s 2015 Scottish Golf Tourism Awards held in St. Andrews.  These annual awards are voted on by the public and are designed to celebrate the hardest working, most accommodating and friendliest clubs in the sport’s home country. The awards are aimed at rewarding excellence in all aspects of golf tourism.  The Village at Machrihanish Dunes’ first award of the night came when The Ugadale Hotel won “Best Hotel” (21-50 Rooms).  According to SGT’s website, this award recognizes “great golfing traditions, a good links course, a golf-friendly staff and superior hotel facilities.”  The Ugadale Hotel is known as one of the finest hotels in all of Scotland and has earned four-stars from the Scottish Tourism Board, as well as annually receiving TripAdvisor’s Certificate of Excellence.  In 2012, The Ugadale Hotel was honored by the Scottish Hotel Awards as Scotland’s “Golf Hotel of the Year”. Machrihanish Dunes’ second award of the evening was a biggie, winning “Best Catering” for its great selection of quality food at reasonable prices and warm service with a smile. Machrihanish Dunes offers its guests 5 different dining experiences to choose from, each with its own unique atmosphere and culinary style, ensuring something to suit any mood and palette. “The team at Machrihanish Dunes continues to excel at providing a world-class hospitality experience for our guests,” said David Southworth, President and CEO of Southworth Development.  “Regardless of whether our guests are visiting for a meal, a round of golf or staying overnight, we strive to deliver the best possible service/experience.  It is an honour to win these awards, particularly knowing it’s our guests who have voted.”    Machrihanish Dunes was also one of four finalists up for the “Best Customer Service” award.  The accolade is a complement to the “Best Golf Experience” designation awarded to Machrihanish Dunes in 2013, just a year after the renovation and reopening of The Royal and Ugadale Hotels in 2012.  The 2015 awards saw more than 26,000 entries, with voting open to the public through the Bunkered Magazine website. The voting was launched at the 2015 Scottish Golf Show in March and was promoted with through Bunkered and Scottish Club Golfer Magazines, both online and via their print publications. For more information or to book reservations, please visit www.machrihanishdunes.com.  Media Contact:  Cindy Lawrence @ +1 617-630-4906 or clawrence@southworthdevelopment.com. About The Village at Machrihanish DunesThe Village at Machrihanish Dunes is an award winning, world-class seaside resort featuring a U.K. Top-100 links golf course (Top 25 in Scotland), four-star accommodations, five casual and fine dining options, a boutique spa, and host of resort amenities.  The Ugadale Hotel & Cottages in Machrihanish offer 22 rooms and suites plus 8 luxurious two-bedroom cottages. The Royal Hotel, with 23 rooms all overlooking Campbeltown Harbour, is located in downtown Campbeltown, a mere 5 miles away.  The resort is ideally suited for golfers; non-golf visitors; golf group visits; family reunions; corporate meetings, events, and retreats; weddings and other social functions; and more.  The course, the first 18-hole course in the U.K. to earn certification from the Golf Environmental Organization, is consistently ranked as one of the most ecologically-friendly courses in the world.  Designed by David McLay-Kidd, it opened in 2009 on a Site of Special Scientific Interest (SSSI), the first course ever to be built on such a site and also the first to be built on the west coast of Scotland in over 100 years.  The Village at Machrihanish Dunes is consistently ranked as one of the ‘best golf experiences,’ ‘best resort,’ and ‘Top-100’ links courses.  For more information on The Village at Machrihanish Dunes or to book reservations, visit www.machrihanishdunes.com.  ### (http://cts.vresp.com/c/?SouthworthDevelopmen/7ad80528f5/0937b54bd6/347abe570a)Southworth Development LLC (http://www.southworthdevelopment.com/), through its affiliated companies, is the primary owner, developer and manager of Machrihanish Dunes Golf Club (http://www.machdunes.com/) and luxury accommodations in both Machrihanish and Campbeltown, Scotland. Editors Note: Grants to the restoration of the Ugadale Hotel in Machrihanish and The Royal Hotel in Campbeltown in cooperation with: Highland and Islands Enterprise (HIE) and the European Regional Development Fund (ERDF) funding support; the Campbeltown Town Centre Regeneration Project (Argyll & Bute Council), a special grant to the Royal Hotel by the Scottish Ministers, through Historic Scotland under the Historic Environment Regeneration Fund.

Interim Report for Saniona AB (publ)

Business highlights in Q3 2015            ·Saniona expects to initiate a confirmatory Phase 2a study with Tesomet in the first half of 2016. ·FDA accepts the University of Pennsylvania Treatment Research Center’s IND for conducting a Phase 2 clinical trial for NS2359 for cocaine addiction. Saniona retains all commercial rights. ·The Board decides to perform a rights issue of SEK 60.7 million with a subscription price of SEK 14.00 per share. The rights issue is secured up to approximately 80 per cent equivalent to SEK 48.8 million. ·Saniona and Pfizer terminate the research collaboration within neurological diseases. Saniona maintains the rights to continue the program. ·Preliminary preclinical toxicology data published for AN363 and announces that it will perform additional studies on a finding seen at higher doses in rats. Subject to a positive outcome of these investigations, Saniona can initiate the clinical Phase 1 trial at the Centre for Human Drug Research in Holland, CHDR. ·New clinical data published which strongly supports the concept for the use of Tesomet for treatment of type 2 diabetes. ·Professor Carl Johan Sundberg is appointed as new member of the Board of Directors at the extraordinary general meeting on September 4, 2015. ·IFRS implemented from the Q2 interim report 2015 in preparation for the planned listing on Nasdaq Stockholm Small Cap in 2016. ·Saniona and Ataxion extend their on-going drug discovery and development collaboration on a three month rolling basis with the aim of identifying a development candidate. ·Rights issue is subscribed to 80.4% and the company raises about SEK 48.8 Million before issue expenses, amounting to around SEK 5.3 million. ·New pre-clinical efficacy data for AN363 published at the Society for Neurosciences 2015 Conference in Chicago along with new scientific data in relation to the AN346 program. Significant events after the reporting period Comments from the CEO ”With the recent completion of the rights issue we are ready for a new era. Within a short period we have gone from being an early stage company to a clinical stage company with the lead compound entering Phase 2 in first half of 2016. I am thrilled by the development in the company,” says Jørgen Drejer, CEO of Saniona. For more information please contact Thomas Feldthus, EVP and CFO, Saniona, Mobile: +45 2210 9957, E-mail: tf@saniona.com Letter from the CEO ”With the completion of the recent rights issue in November, Saniona is now positioned to enter into a completely new era. We are leaving the early stage with only preclinical programs behind us. We are entering a stage where several programs can enter the clinical phase, two programs in Phase 2 and potentially one program in Phase 1. Still we have retained our broad portfolio comprising a number of exciting programs and opportunities. We are primarily focusing on the three programs, which can enter clinical phase: ·Tesomet is planned to initiate Phase 2a studies in the first half of 2016 for type 2 diabetes. Tesomet is a combination of a weight-loss drug candidate, tesofensine, and a beta blocker, metoprolol. ·NS2359 obtained an IND by the FDA in August to start Phase 2 clinical trials in the US for cocaine addiction. These studies can bet started without significant investments by Saniona. Researchers at the University of Pennsylvania are currently applying for public funds to support this study. Saniona retains all rights. ·Regarding AN363, provided that the results of the additional toxicological studies in rats are positive, we can initiate Phase 1 clinical studies in 2016 for neuropathic pain. With respect to Tesomet, we are looking very much forward to initiate our Phase 2a clinical study in the first half of 2016. It represents to a large extent a confirmatory study of the results we have seen in pre-diabetes patients. A retrospective analysis of existing data from a previous clinical Phase 2 trial in humans shows that tesofensine reduces the glycemic parameters in individuals with pre-diabetes. In addition, a retrospective analysis of a Phase 1 study with tesofensine and metoprolol shows that metoprolol prevents the increase in heart rate caused by tesofensine in human volunteers. A part of our strategy is to develop selected programs internally through the early phases of drug development in order to build further value into these programs before out-licensing to third parties. The largest value increase is often generated during or upon completion of Phase 2a clinical studies. We believe that we can create significant value in the above-mentioned programs. They have a very large market potential with sales of existing products in the single or double digit billion dollar range, they are addressing indications with significant unmet medical need and importantly, Saniona will subject to sufficient funding be able to complete Phase 2a clinical trials. Despite the focus on the above three programs, we shall not forget Saniona’s platform and broad portfolio of other programs. Especially our collaboration with Ataxion, which was extended recently. Furthermore, although that Pfizer and Saniona recently have terminated their collaboration due to strategic decisions at Pfizer, we do see significant opportunities for developing this program with another partner. We are continuing working on business development activities in respect to various programs and we see good opportunities to enter into new agreements on our platform where we have several programs in early stages. Therefore, we are convinced that Saniona has an exciting future. I want to take this opportunity to thank all the shareholders and not least the guarantors and presubscribes who supported us in the last rights issue. Thank you." Jørgen Drejer CEO, Saniona AB

Businesses Urged to Invest in Back up Power Ahead of Winter Power Shortages

From hospitality to healthcare, data centres to doctor’s surgeries, businesses and organisations are being urged to make sure they have back up power in place ahead of the winter. With the closure of coal power stations, Britain’s power supply is dangerously low, with many predicting blackouts this winter. With spare capacity at just 1.9% of expected demand, power is in short supply – which could mean blackouts and lost profits this season. Businesses of all sizes should be considering industrial diesel generators to keep the lights on and the company trading. Max Generators stock a huge range of new and used industry standard generators, which act as a back-up power source for companies which can’t afford an outage. In addition to the UK’s worrying power shortage in peak times, the nation also has to be prepared for storms and inclement weather which can also cut power. William Macdonald, Managing Director of Max Generators said, “Businesses need to be more equipped than ever this year, as the fear of blackouts and power cuts is well justified. Four years ago, The National Grid’s spare capacity was 17% - now it has fallen to just 5.1% and it would be even worse if they hadn’t bought extra supplies for the cold weather ahead. “As a business, you need to be prepared for absolutely anything. There is no doubt that investing in an industrial generator is an essential part of any disaster recovery plan right now – it’s better to be safe than sorry. For buildings such as schools and hospitals, it’s about much more than keeping the money flowing in – it’s keeping the public safe.” Diesel generators make ideal back-up power supplies as they can be automatically kick-started into action with an Automatic Transfer Switch and provide a resilient power source. Even blackouts or power outages of a short period such as an hour or less can have a significant impact on business operations – especially if it relies heavily on technology. As industry experts, Max Generators provide knowledge, advice and a bespoke consultation service for each business, to ensure they choose the most suitable option for their power supply. The company specialises in a range of different brands to offer the best on the market, and also supply refurbished generators to meet all budgets. For more information about diesel generators and how they can help safeguard your business this winter, visit: www.MaxGenerators.com

Innovation Insight for the SA Brands’ Packaging Industry

Arno Rabie, Managing Director of UK package innovation marketing strategists, Smooth HIP Ltd, is no stranger to brand packaging in South Africa. Not only is he South African by birth, but has spent considerable time in Europe, and of late is helping to nurture innovation and encourage the addition of added value in South African on projects in the packaging industry sector. Arno Rabie has over 25 years’ international experience, including 15 years in the Southern African markets, as well as an extensive industrial network he has built throughout Asia and Europe. He is a man who is very much in demand internationally for his expertise in innovation. He was invited to Crain's Conference in Nice (France) in November 2015 as guest speaker on “Trends in the International Closures’ Industry and to speak at Berlin’s AIM conference in June 2015 on “Innovation and Added Value in Updates in the Packaging Industry”, where he was possibly the only invited South African key note speaker in the conference’s history. Arno has also featured for his innovation and insights in international magazines such as “Plastics in Packaging” and “Injection World Magazine”. He says: “Having worked over the past few years with global package manufacturers such as German-company Bericap as just one example, with its 22 factories in 19 countries, I have found many thoughts and concepts that can be turned into profitable reality come to light! “There seems to be a lack of innovation management across packaging companies in South Africa that needs to be addressed if the companies are to compete more successfully and become more profitable for Brands. They need to cast aside their traditional and rather old values, in particular, keeping in line with traditional marketing and brand managers creative team objectives, and break out. The Packaging innovation can become key to marketing strategy. He aims to help facilitate innovation by working with and offering innovative collaboration on projects. Having spent time with packaging managers in companies such as Danone, Britvic and Tesco (the largest retailer in Europe), he possesses the valuable insight to facilitate a change in the outlook and approach to creative bridging with manufacturers’ opportunities with low investment innovation and projects with the brand teams. He hopes this will encourage a valuable and ultimately bottom-line change in manufacturers’ outlook for investment in product innovation with the brand. The greatest impact on the consumer retention is the influence and experience with the package through use. Resultant from his recent base in South Africa, Arno is now in the position of bringing this vital information in-house to both the project and research and development teams in packaging manufacturing companies and brands. He says that the key legislation with regards to EU packaging constraints for South Africa also have an impact, and that South African manufacturers have to stay updated (with EU legislation), otherwise it can cost them dearly. “Innovation is the key and I want to ensure I can pass on the vital necessity of project and research and development collaboration between teams in South African packaging manufacturing companies and brands.  “Consider the printing of electronics and sensors with ink and their interaction with products, even packaging. This brings an entire new era to low investment innovation for manufacturers and brands.  Many innovators and their projects lack a full view of the picture of understanding manufacturer’s restrictions and outlook. Neither do they know the brand’s greater objectives not having the ability to merge them with a low investment product’s added value for the consumer able to absorb the product price. This limits new packaging innovation ventured by the brands for the consumables’ industry. “To impact and survive on international markets and become key world players, I want to demonstrate to South African packaging companies precisely how that they can do this and subsequently increase their bottom lines.” He concludes: “While working on projects in SA, I am taking the opportunity to offer packaging companies some invaluable insight into different brands outlooks, coupled with guidance that I will share in a one-day workshop. It is my intention to also share consumer trends from Europe, some guides from the biggest retailer in Europe. In addition, I propose to condense some vital information from these conferences considering the huge lack in SA representation. However, I also aim to understand each company's customer needs for their consumers and to offer added value for product development. The consumer retention is the result with the experience with the package through use that is becoming more critical with product diversification.”

Rejlers and Stockholm Cycling Club start elite teams for men & women

Next year SCC will have competitive teams in both the men's and women's elites, with a clear goal of competing for medals in the Swedish championships in both individual road races and time trials. The teams assemble some of the Stockholm region’s best competitive cyclists, combining young promising cyclists and more experienced competitive cyclists. “After starting cycling together in the 2014 season, the 40 or so members in the original group, with the help of our sponsor technology consultant Rejlers, have continued to develop,” comments Thomas Backteman, chairman of the Stockholm Cycling Club. “In 2015, we took the plunge and formed a club, as several members of our team, the Rejlers Cycling Team, wanted to start competing together. Now we are taking the next step of bringing together some of the Stockholm region's best competitive cyclists in both the men’s and women’s sports. It’s great to be able to help create a new competitive cycling team in Stockholm, because it’s a way of strengthening cycling as a sport throughout Sweden,” says Thomas Backteman. “At Rejlers we’ve taken a strategic approach to health for many years now, and we’re investing in different initiatives to get our employees to feel healthy; cycling is just one of them. In collaboration with the legendary Swedish-owned cycle brand Bianchi, I have travelled around the Nordic countries handing out bikes at Rejlers' offices. These bikes can be used by staff to get to customer visits or to take part in one of the amateur races arranged all over the Nordic region", says Peter Rejler, President and CEO of Rejlers. About Stockholm Cycling Club / Rejlers Cycling TeamAs Stockholm's only focused club for elite athletes Stockholm Cycling Club provides a link between competition and exercise. The club offers ambitious athletes and elite cyclists constant development. Together we lift the team and the team is greater than any single individual - the team is stronger than the ego! The club started in 2015 with the help of Rejlers and has today over 160 active members including teams and active members in both women's and men's class competing at the elite and masters level in Sweden and internationally. The club has become a given element not only in the Swedish racetracks but also in all the major races in Sweden and abroad. SCC will represent Rejlers in all the big races in Sweden and in several international races. SCC / Rejlers Cycling Team started in 2015 a collaboration with the Psychiatry Fund to support the work against mental illness. The collaboration will continue and intensify during 2016. For further information:Peter Rejler; President and CEO, +46 70 602 34 24, e-mail: peter.rejler@rejlers.seLisa Rejler; Head of Investor Relations & CSR, +46 70 399 08 06, e-mail: lisa.rejler@rejlers.seRejlers is one of the largest engineering consultancy firms in the Nordic region. Our 2,000 experts work with projects within the areas of Building and property, Energy, Industry and Infrastructure. With us, you will meet specialist engineers with the breadth, cutting edge expertise and not least energy to create the results you want. We are continuing to grow rapidly and our activities are spread across 80 locations in Sweden, Finland and Norway. In 2014, Rejlers had revenue of SEK 1.7 billion and its Class B share is listed on Nasdaq Stockholm.

CTT Systems receives Cair™ VIP humidification order for one Boeing BBJ 787

“This is our third VIP humidification order for a BBJ 787 VIP aircraft completion and the 11th Cair™ VIP aircraft order during the past 12 months! These endorsements demonstrate our strong VIP market position and manifest the growing demand for inflight air quality and wellbeing. Dry cabin air is no longer accepted as an unwanted nuisance in VIP aircraft,” says Peter Landquist, Vice President Sales & Marketing of CTT Systems. Cair™ humidification reduces negative health and wellbeing impact from dry air on long-haul flights by maintaining the Relative Humidity on ground like levels that the human body is used and adapted to (i.e. human body and its membranes will not be exposed to quick de-hydration that otherwise is the case in an extremely dry cabin). The Cair™ humidification system hereby improves passenger relative comfort, health and rest by generating a relative humidity of approx. 20%, compared to 3-5% without our humidifiers. A higher humidity reduces dry air related problems (e.g. fatigue, jet-lag, red eyes, dry skin, spread of virus diseases). The humidifiers are based on evaporative cooling technology that effectively precludes the transfer of bacteria and improves air quality by reducing particles in the cabin air. Cair™ keeps humidity in balance with Zonal Drying ™ anti-condensation system that enables cabin humidification without any moisture related problems. About CTT SYSTEMS CTT Systems is the market leading provider of humidity control products in aircraft, including anti-condensation systems preventing moisture problems in the aircraft and humidifiers for in-flight comfort and wellbeing for crew and passengers. Our products are offered for retrofit installations and line-fit on A380, A350XWB and Boeing 787. The crew humidifier is standard in all crew rest compartment fitted Boeing 787 aircraft and optional in the crew rest compartment on A380 and A350XWB program. The flight deck humidifier is optional on both the Airbus A350XWB and Boeing 787 aircraft. The Airbus A350XWB is first to offer Cair™ humidification as SFE for First/Business Class (Zone1-3). The Zonal Drying™ anti-condensation system is basic equipment in all Boeing 787 aircraft and optional (as Buyer-Furnished-Equipment) on the Boeing 737NG program. The Zonal Drying™ is basic equipment on all Boeing 787 “Dreamliner” aircraft and the humidifiers are standard in all crew rest compartment fitted Dreamliner aircraft and optional for flight deck. The flight deck humidifier is optional on the A350XWB aircraft, the crew rest compartments humidifiers are optional on both A380/A350XWB and the Zonal Drying™ and Cair™ systems are optional on the A350XWB aircraft. Also visit: www.ctt.se   For additional information: Torbjörn Johansson, President, CTT Systems AB.Tel. +46-155-205901 alt. mobile. +46-70-665 24 46, or E-mail: torbjorn.johansson@ctt.se Peter Landquist, VP Sales, Marketing & Customer Support CTT Systems AB.Tel. +46-155-205902 alt. mobile. +46-70-665 24 45, or E-mail peter.landquist@ctt.se This information is disclosed by CTT Systems AB in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements. The information was submitted for publication on November 20, 2015 at 13.00 (CET).

OxySure (OXYS) 3Q15 Results - 14 Consecutive Growth Quarters - Video News Alert on InvestmentPitch.com

Vancouver, British Columbia-- (Marketwired - November 20, 2015) - Medical device innovator, OxySure Systems (OTCQB: OXYS) announced results for the 3rd quarter 2015, reporting 14 consecutive quarters of growth. InvestmentPitch.com has produced a "video news alert (http://www.investmentpitch.com/#sthash.d3I1QixO.dpuf)" which discusses the company’s financial results. If this link is not enabled, please visit www.InvestmentPitch.com and enter "OxySure" in the search box.  (http://www.investmentpitch.com/#sthash.d3I1QixO.dpuf) If you cannot view the video above, please visit: http://www.investmentpitch.com/#sthash.d3I1QixO.dpuf Julian T. Ross, Chairman and CEO of OxySure stated: "This has been a good building quarter for us. We were able to bring strong management to the opportunities and challenges along the way and we are pleased with the exemplary results." OxySure pioneered a safe and easy to use solution to produce medically pure oxygen from two dry, inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. In addition to oxygen products for public/lay responder usage, OxySure also markets emergency medical solutions including AEDs (Cardiac Science, Philips, Zoll, Physio Control, Defibtech, and HeartSine), Quickclot Bleeding Control solutions, resuscitation products and pulse oximetry products. 3Q 2015 Results Highlights Included: • Total revenue up 39% to $1,138,380 (3 months) • Total revenue up 52% to $2,809,553 (9 months) • Gross profit up 12% to $558,254 (3 months) • Gross profit up 40% to $1,484,388 (9 months) • Total cash up 210% to $2,006,312 at September 30, 2015 from $647,093 at December 31, 2014 • Working capital surplus up 253% to $1,479,075 at September 30, 2015 from $418,734 at December 31, 2014 • Total assets up 76% to $4,424,003 at September 30, 2015 from $2,511,448 at December 31, 2014 • Stockholder equity up 103% to $2,180,918 at September 30, 2015 from $1,074,788 at December 31, 2014. • TTM revenue $3.4 million • Revenue run rate approaching $5 million • On track for revenue run rate of $10 million in 2016 • On track for breakeven in 2016 When asked about future plans, Ross stated: “Looking forward, we remain on track with the launch of at least one new solution in 2015,” added Ross. “Also, we have started working with our medical advisors on laying the ground work for our direct to consumer campaign addressing “At Risk” markets such as Asthma and Immunology markets. We expect to continue our efforts to grow our direct sales force. We have made additional progress and will be continuing our work on the Nasdaq uplisting process. Finally, our growth plan is working and our investments are paying dividends. We are especially excited about working towards one of our next key milestones, which is to reach the $10 million revenue run rate number and breakeven some time in 2016.” For more information, please visit the company's website www.oxysure.com. In Canada, investor relations is handled by Bettina Filippone of Renmark Financial Communications, who can be reached at bfilippone@renmarkfinancial.com.  In the US, please contact Jon Cunningham at Redchip Companies, who can be reached at jon@redchip.com. About InvestmentPitch InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports. CONTACT: InvestmentPitch.com Barry Morgan, CFO bmorgan@investmentpitch.com

Indianapolis Family Receives a Patio Makeover from Simonton and This Old House

INDIANAPOLIS, Ind. – Simonton Windows & Doors, a nationwide provider of vinyl windows and patio doors, in partnership with This Old House, an Emmy-winning home improvement series and brand, completed a patio makeover for a local Indianapolis homeowner who won the Party on the Patio contest. The homeowner, Courtney Jennings, received a $10,000 patio makeover and a new Simonton Inovo patio door. The contest asked participants to submit a photo of their existing patio and how they would use the $10,000 to improve their outdoor living space. With over 4,500 entries, homeowners nationwide sent snapshots of their patios in need. However, Jennings’ photo of her aged deck and door made her the clear choice for the patio makeover. “When we saw Courtney’s outdoor living space, we knew we would be able to help her create the patio of her dreams, “said Heather Schreiber, senior manager of communications and digital marketing for Simonton. “At Simonton, we pride ourselves on transforming people’s homes. Unlike many improvement projects, windows and patio doors create a beautiful look for the inside and outside of your home, which means Courtney will be able to enjoy a beautiful view in the winter when she’s in her kitchen looking outside, and in the summer, she’ll be able to host amazing gatherings on her brand new patio!” Jennings learned she was the contest winner in October and the process of transforming her patio was quickly underway. “I didn't believe it at first! It didn't seem real until I met everyone at my house,” Jennings said. “We are doing so much to our fixer-upper, I thought it would be nice to have something done fast and by someone else. All the contacts and contractors were so wonderful to work with and really wanted to make sure we got what we wanted.” Indianapolis area contractors, G & C Ramsey Construction Inc., were chosen to complete the patio makeover which included installing the new Inovo patio door, re-building the deck and creating a pergola for Jennings’ outdoor space. In addition to winning a patio makeover, Jennings received $1,000 to throw a party on her newly transformed patio. “I'm excited to have a safe and gorgeous deck to share with friends and family, and shade so we can use it during the day. We can now have a party with plenty of room for my husband to grill and friends to hang out nearby,” Jennings said. “During the warmer months, my husband and I relax after work on the deck daily. And now with the added space, I'm sure we'll have more gatherings.” The media event is Wednesday, Nov. 25 from 9 a.m. – 12 p.m. at Jennings’ home, 8401 Acton Road, Indianapolis, IN. The complete patio makeover will be featured on ThisOldHouse.com beginning in December. About Simonton Windows & Doors Part of Ply Gem Holdings, Inc. (NYSE: PGEM), Simonton delivers vinyl windows and patio doors throughout the United States and North America. Since 1946, Simonton has helped to enhance the homes of their customers. After nearly 70 years, they continue provide homeowners with high-quality windows and doors, and consumers have repeatedly voted Simonton Windows highest in customer satisfaction. Simonton is headquartered in Columbus, Ohio. 

Iveco Stralis Hi-Way joins agricultural produce haulier P. Harper & Sons’ fleet

In a hard won conquest deal, Iveco has delivered its first new heavy truck to agricultural produce haulier P. Harper & Sons in more than seven years. The new Stralis Hi-Way AS440S46TX/P 6x2 twin-steer tractor unit joins the national haulier’s 16 vehicle fleet, which operates from its storage, grading and distribution centre in Ramsey, Cambridgeshire. One of the key factors for the decision was the new vehicle’s projected low total cost of ownership over its expected five year working life on the fleet. To ensure optimum performance and minimum downtime the Stralis has been supplied on a 140,000km per annum R&M agreement with Guest Truck and Van – one of the largest Iveco dealer groups in the UK. Under the deal, Harper’s will be able to take advantage of full vehicle servicing and maintenance – along with scheduled safety inspections, digital brake testing and tachograph calibration – with the guarantee that work will be undertaken by manufacturer trained technicians. Nigel Harper, P. Harper & Sons Managing Director, says: “We knew from past experience that Iveco produces an excellent vehicle and the latest generation Stralis ticked all the boxes. On top of this Bal Singh at Guest Truck and Van offered us a competitive repair and maintenance package and his personal guarantee that we would receive first class service throughout the vehicle’s life on our fleet. That, combined with the all-round versatility of the Stralis Hi-Way, was enough to tempt us.” Harper’s new Stralis tractor unit is powered by the latest Iveco Cursor 11 engine which produces up to 460 hp between 1,500 and 1,900 rev/min, and up to 2,150 Nm of torque between 925 and 1,500 rev/min. This is achieved thanks to Iveco’s patented HI-SCR system, which has been designed to meet Euro VI emissions standards without the need for exhaust gas recirculation. The new technology assists in reducing the vehicle’s weight and further optimising fuel performance, whilst the simplicity of the SCR-only approach means long service intervals for the diesel particulate filter of up to 600,000km. In addition to the wealth of standard features the new Stralis Hi-Way has been equipped with lightweight alloy wheels, axle load indicators and Iveco’s technology-rich integrated satellite navigation, infotainment and telematics package, IVECONNECT. The new vehicle is finished in Harper’s distinctive blue livery and features a Kelsa light bar mounted on the roof. P. Harper & Sons Ltd was established in 1962 and provides a dedicated 24/7 transport service to the agricultural industry throughout the UK. The family owned company also provides on-site storage, produce grading and re-distribution through Harpers Grading and Storage Services. Iveco Iveco is a brand of CNH Industrial N.V., a World leader in Capital Goods listed on the New York Stock Exchange (NYSE: CNHI) and on the Mercato Telematico Azionario of the Borsa Italiana (MI: CNHI). Iveco designs, manufactures and markets a wide range of light, medium and heavy commercial vehicles, off-road trucks, and vehicles for applications such as off-road missions. The brand’s wide range of products include the Daily, a vehicle that covers the 3 – 7 tonne vehicle weight segment, the Eurocargo from 6 – 19 tonnes, the Trakker (dedicated to off-road missions) and the Stralis, both over 16 tonnes. In addition, the Iveco Astra brand builds off-road trucks, rigid and articulated dumpers as well as special vehicles. Iveco employs close to 21,000 individuals globally. It manages production sites in 7 countries throughout Europe, Asia, Africa, Oceania and Latin America where it produces vehicles featuring the latest advanced technologies. 4,200 sales and service outlets in over 160 countries guarantee technical support wherever an Iveco vehicle is at work. To download supporting imagery: http://news.cision.com/ivecoFor further information about Iveco: www.iveco.comFor further information about the Iveco dealer network: http://www.iveco-dealership.co.ukFor further information about CNH Industrial: www.cnhindustrial.com For more information contact: Nigel Emms, Director, Brand & CommunicationIveco Ltd Tel. +44 (0)1268 885911 nigel.emms@iveco.com www.iveco.co.uk 2619/15 ref : IVECO 15049

New Abstral® partner in the US

Uppsala, Sweden – November 20, 2015 – Orexo AB (publ) today announced that the US Abstral partner, Galena Biopharma Inc., has divested its Abstral business to the privately held company Sentynl Therapeutics Inc. as a consequence of Galena’s change of strategy to focus on its clinical development programs. The divestment is effective as of November 19, 2015 and Orexo terms are unchanged and passed on from Galena to Sentynl. “We are pleased to see the interest in Abstral that has been revealed during Galena’s divestment process and pleased to have a new and dedicated partner in Sentynl. We are confident that Sentynl will manage to continue to grow the Abstral business in the US,” said Nikolaj Sørensen, CEO and President of Orexo AB.   For further information, please contact:Nikolaj Sørensen, President and CEO, Orexo ABTel: +46 703 50 78 88, E-mail: ir@orexo.com About Abstral®Abstral is the leading fast-acting fentanyl product in EU intended for treatment of breakthrough pain in cancer patients. Abstral employs Orexo’s proprietary sublingual delivery technology (under the tongue). After the product development Abstral was out-licensed to Kyowa Hakko Kirin Co., Ltd. and the European subsidiary ProStrakan Group plc, which still holds the rights in the Japan and EU respectively, whereas Galena Biopharma Inc. held the rights for Abstral in the US until the divesture to Sentynl Therapeutics Inc. as of November 19, 2015. For information about Abstral, please visit www.abstral.com. About OrexoOrexo is a specialty pharmaceutical company commercializing its proprietary product Zubsolv® for treatment of opioid dependence in the US. Zubsolv is an advanced formulation of buprenorphine and naloxone using Orexo’s unique knowledge and expertise in sublingual drug delivery. R&D is focusing on reformulation of known substances to new improved products that meet great unmet medical needs by using its patented proprietary technologies. Orexo’s share is listed on Nasdaq Stockholm Exchange Mid Cap (STO: ORX) and is available as ADRs on OTCQX (ORXOY) in the US. Orexo’s global headquarters and R&D are based in Uppsala, Sweden. For more information please visit www.orexo.com and www.zubsolv.

NHS Facing Worst Winter Ever – RMR Recruitment Can Help Fill The Gaps

RMR Recruitment, one of the country’s leading locum agencies, is set to help the NHS through what is billed to be one of the ‘worst winters ever’, as budget cuts, bed shortages and ever-increasing waiting lists threaten the health and wellbeing of the British public. Four in five NHS trusts reported a deficit for the second quarter of 2015, while the number of patients at foundation hospitals waiting in excess of six weeks for simple diagnostic tests has soared to 10,800 – up 42% on last year. Four out of ten NHS trusts have had to close maternity wards due to staff cuts, and budget problems could mean 23,719 nurses, 9,279 hospital registrars and 3,449 hospital consultants losing their jobs. RMR Recruitment is an approved provider of qualified, professional doctors and nurses to various NHS trusts across the country – and the team predict an incredibly busy winter as the NHS attempts to cater to demand despite the various crises it faces. Richard Rowley, Director of RMR Recruitment, says, “The issues facing the NHS are widespread and worrying – especially when you hear that as much as 4% of the entire NHS workforce could lose their jobs. The NHS is undoubtedly in crisis – and we’re on hand to step in and help wherever we can, providing excellent doctors and nurses to fill urgent roles and helping to keep the NHS on its feet through what will be a particularly challenging period.” RMR Recruitment is currently recruiting doctors and nurses from all over the country, to ensure they’ll be able to meet any demands the NHS asks of them. With an honest approach to medical recruitment, RMR prides itself on transparency and ethics, with a unique end-to-end services that benefits clients and candidates alike. The locum agency already has a multitude of open roles that need to be filled in the run-up to Christmas, when A&E wards are often overrun and waiting times for operations and tests are typically long. Doctors and nurses signing up will receive access to a bountiful database of jobs from all over the country – and referring an equally qualified friend will see both parties receive an added bonus. Mr Rowley adds, “At this time of year, the NHS can’t afford to spend time conducting exhausting recruitment drives. RMR Recruitment offers the solution, with a seamless solution that supplies medical staff of a very high calibre. We do our jobs so that the pressured, busy individuals working in the NHS can continue to do theirs, rather than having to do the work of two people, or spending time looking for a new recruit.” For more information about RMR Recruitment, visit the site: http://www.rmrrecruitment.co.uk/


Alma Media Corporation       Stock Exchange Release         November 20, 2015 at 4.30 pm (EET) ANNOUNCEMENT UNDER CHAPTER 9, SECTION 10 OF THE SECURITIES MARKETS ACT: MARIATORP OY’S SHAREHOLDING IN ALMA MEDIA CORPORATION Alma Media Corporation has received on 20 November 2015 an announcement pursuant to section 10, chapter 9, of the Securities Markets Act from Mariatorp Oy, that the agreement it announced on 12 November has been carried through, and that due to the increase in Alma Media’s number of shares as a result of the completion of the exchange offer on Talentum’s shares, Mariatorps’ holding of the shares and votes in Alma Media has fallen below the threshold of 20%. Issuing company and its business ID: Alma Media Corporation, 1944757-4 Complete name and business ID of the shareholder: Mariatorp Oy, 2690035-7 Basis of announcement: Acquisition or disposal of shares or voting rights and the rise of issuing company’s number of shares. Date of transaction and exceeding the threshold: 20.11.2015 Below threshold: 1/5 (20%) of shares and votes Holding of Mariatorp Before change in holding: Number of Alma Media Corporation shares 15,474,774 Percentage of shares and votes 20.50 % After the change in holding: Number of Alma Media Corporation shares 15,474,774 Percentage of shares and votes 18.78 % The registered number of the Alma Media Corporation shares is 82 383 182 shares, which entitle to a total of 82 383 182 votes. ALMA MEDIA CORPORATION Rauno Heinonen Vice President, Corporate Communications and IR Further information: Mikko Korttila, General Counsel, tel. +358 (0)10 665 2201 Distribution: NASDAQ OMX Helsinki Ltd, Main Media, www.almamedia.fi Alma Media in brief Alma Media is a media company focusing on digital services and publishing. In addition to news services, the company’s products provide useful information related to lifestyle, career and business development. The services of Alma Media have expanded from Finland to the Nordic countries, the Baltics and Central Europe. In 2014, the company employed an average of 1,830 professionals (excluding deliverers), of whom approximately one quarter worked outside Finland. Alma Media’s revenue in 2014 totalled approximately EUR 295 million. Alma Media’s share is listed on NASDAQ OMX Helsinki. Read more at www.almamedia.com.

iFoodbag launches revolutionary packaging solution - A unique product, now displayed for the very first time

Having recently signed an agreement with global packaging company Mondi, it’s time for iFoodbag to take the next step. Now we are presenting a partnership with Mat.se that will deliver food in a whole new way, in cooperation with a large car producer. Which car producer is to be presented in the coming days. This deal means that Mat.se, along with the car manufacturer, will enable smooth online grocery shopping directly from the car with delivery the next day. This is also where our unique product comes in. The iFoodbag® is a temperature-controlled packaging solution that can protect chilled and frozen goods for up to 24 hours, unlike anything else available on the market today. Welcome to the press conference for more details and a first viewing of iFoodbag’s unique product. Location: Sturegallerian, Stureplan 4C, 4th floor. Time: Monday, 23rd of November, at. 1:00 p.m. to 3.00 p.m. For further information please contact: Karl Fallgren, CEO and founder of iFoodbag AB Phone: +46 76 163 47 03 E-mail: karl.fallgren@ifoodbag.se Gustaf Graah-Hagelbäck, Inmema PR Phone: +46 70 719 34 84 E-mail: gustaf.graah-hagelback@inmema.com About iFoodbag: WE SIMPLIFY LIFE. iFoodbag is a Swedish start-up company and newcomer in the packaging industry. It was founded in 2013 and developed the unique paper bag of that name, the iFoodbag®. The iFoodbag® is an innovative bag made from a composite material that can protect chilled and frozen food for up to 24 hours as a passive packaging solution. The iFoodbag® is intended to solve inter alia the following problems: • E-commerce logistics challenge: costs and product quality • Improved quality for chilled and frozen items • Environmental waste The company has received a number of awards for its new approach and start-up idea. For further information, please visit www.ifoodbag.com.

Vigmed publishes prospectus regarding the previously announced rights issue

The prospectus regarding Vigmed Holding AB’s (publ) (“Vigmed” or the “Company”) rights issue has been approved and registered by the Swedish Financial Supervisory Authority and is available on the Company’s website www.vigmed.com and on Remium’s website www.remium.com. Vigmed has engaged ABG Sundal Collier as financial advisors and Mannheimer Swartling Advokatbyrå as legal advisor in connection with the rights issue. Vigmed discloses the information in this press release pursuant to the Swedish Securities Markets Act.The information was provided for public release on November 20, 2015 at 17:35 CET. Important information This press release is not an offer regarding shares or other securities issued by Vigmed Holding AB (publ) (the “Company”). This press release may not be distributed in or into the United States, Canada, Japan, Australia or in any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law. Nor may the information in this press release be forwarded or reproduced in a manner that contravenes such restrictions or gives cause to such requirements. No securities issued by the Company have been or will be registered under the United States Securities Act of 1933, as amended (“Securities Act”) and may not be offered, sold or otherwise transferred, directly or indirectly, in or into the United States except under an available exemption from, or in a transaction not subject to, the registration requirements under the Securities Act. No public offering will be made in the United States. In member states within the European Economic Area (EEA) (other than Sweden) which have implemented Directive 2003/71/EC (the “Prospectus Directive”), this press release is directed only at qualified investors as defined in the Prospectus Directive. This press release may contain certain forward-looking statements that reflect the Company’s current views on future events as well as financial and operational performance. Words such as “intend”, “assess”, “expect”, “may”, “plan”, “believe”, “estimate” and other expressions entailing indications or predictions of future development or trends, and which are not based on historical facts, constitute forward-looking statements. Forward-looking statements inherently involve both known and unknown risks and uncertainties as they depend on future events and circumstances. Forward-looking statements information is not a guarantee of future results or performance, and the actual outcome may differ materially from the information set forth in the forward-looking statements. A prospectus prepared in accordance with the Prospectus Directive have been published on November 20, 2015 and is, with certain restrictions, available at www.vigmed.com.

Favorable verdict for Inventist in IO Hawk lawsuit for patent Infringement

Inventist, the inventor of the Hovertrax (also known as self-balancing scooter and hoverboard) has now won its first case against the largest of the patent infringing companies, IO Hawk, and will continue to seek all that violate its patent.  Anyone who willingly and knowingly sells infringing units is subject to potential liabilities. Inventist is now actively moving to stop shipments of infringing units at port and have recently detained six large containers of illegal goods headed for the US.  Inventist owns U.S. Patent No. 8738287 (the ‘278 Patent), which is directed to self-balancing vehicles with independent foot platforms.  The Patent covers the recent wave of self-balancing vehicles that are infringing, selling under various names including ChicSmart, PhunkeeDuck, Swagway and E-Boards. Vehicles may have slight variations in outer shell designs and or features such as lights or Bluetooth. The ‘278 patent is broad and covers all of these variations.  The patent covers motorized self-balancing scooters with independent foot placement controls.  Regardless of variations in design and features, if it doesn’t say Hovertrax - it is infringing. The Hovertrax can be purchased at Brookstone stores nationwide starting in December and online now at Brookstone.com and Inventist.com A Timeline of Events: · Shane Chen filed a U.S. patent for his device Feb. 11 2013. · This patent was approved May 27, 2014. · Chen filed for a Chinese patent March 20, 2013. · The patent was granted August 28, 2013. · The Hovertrax Kickstarter video was published on YouTube Feb 25, 2014. · August 21, 2014, Chic publishes their video for the Chic S1. · In fall of 2014, Chic brought the S1 to the 116th Canton fair. · PhunkeeDuck.com is registered Jan 29, 2015. · IOHawk.com is registered Dec 17, 2014. · IO Hawk showed off their devices at the 2015 Consumer Electronics Show in Las Vegas. · The lawsuit, mentioned here: http://nheller.com/a-game-of-hoverboards/, states that: · “At the CES trade show, representatives from Inventist inspected the IO HAWK Product and advised John Soibatian of Soibatian Corporation that the IO HAWK Product infringed the ‘278 Patent. Representatives from Inventist showed Mr. Soibatian the ‘278 Patent. Accordingly, Soibatian has had actual notice of Inventist’s claim of infringement since on or about January 9, 2015. Soibatian denied infringement.” · “On January 22, 2015, counsel for Inventist and Mr. Chen sent Soibatian a detailed letter explaining how the IO HAWK product infringed the ‘278 Patent, and requested that Soibatian cease and desist the infringing acts. Upon information and belief, both the notice at the CES trade show and the letter notice of January 22nd were prior to Soibatian’s first sale of an infringing IO HAWK device. Yet, despite this notice and explanation, Soibatian began to sell the IO HAWK product in approximately February 2015 and has continued to infringe since that time, including expanding promotion of the infringing IO HAWK product.” · As of August 26th 2015, Mark Cuban told TMZ that he had partnered with Chen around August 12th 2015. · June 16th 2015, Chen launched his lawsuit against IO Hawk. · November 2015, Chen revokes the partnership with Cuban and moves forward with a partnership with Razor Industries. · December 2015, Hovertrax can be seen nationwide in large retail locations. 

Friday Sermons used for condemnation of extremism & ISIS

Scholars and Mosques throughout the United Kingdom have used their Friday sermons and pulpits to strongly condemn the extremist group known as Islamic State and the recent Paris attacks. Strong condemnation was given against all forms of extremism. The Central Association of Sunni Muslims U.K. (Markazi Jamat Ahle Sunnat UK & Overseas ), a large Sunni umbrella body based in U.K. had called upon all Islamic Scholars in U.K to use today’s Friday sermons for strong condemnation of the recent Paris attacks. Speaking to a large crowd at Jamia Islamia Ghousia Trust in Luton, senior Islamic Scholar Allama Qazi Abdul Aziz Chishti stated “ We have seen one of the worst attacks in the history of France take place on Friday, I along with other scholars in UK have strongly spoken out against the extremists which carried out the attack, we have also written to the Ambassador of France as well as PM Cameron stating our disgust and sending our condolences. My senior organisation has asked for today to be a day of condemnation against these barbaric acts and to make clear that they have nothing to do with Islam” Similar speeches were given throughout U.K. speaking in Birmingham Senior Cleric Syed Zafrullah Shah Stated “ we stand strongly against all forms of extremism and our thoughts are with the loved ones of the deceased. We also ask the people of United Kingdom not to let the enemies win and to stay united in this time of difficulty” Speaking at Leicester Central Mosque, Senior Imam Allama Shahid Raza OBE during his sermon stated “ We denounce all forms of extremism and terrorism, Islam is a religion whose fundamental principal is peace not war. Those trying to tarnish the name of Islam and Muslims will never succeed. The leaders of this country and in particular the USA need to make it clear that these barbaric attacks have nothing to do with Islam. We stand united with our brothers and sisters in humanity against these evil wrongdoers” Further north of U.K. President of the Central Association of Sunni Muslims speaking to a packed mosque in Halifax at Jamia Al Zahra stated “May the curse of Allah Almighty be on the terrorists who took these innocent lives. These attacks are an insult not only to Islam but to the whole of Humanity” Similar speeches denouncing the barbaric attacks and ISIS were given at various mosques and Islamic centres all over the United Kingdom. It was also asked that the British government do more to make clear that the religion of Islam and Muslims have nothing to do with these acts and this ideology. Recent remarks by President Obama at the G20 summit asking Muslims to ask themselves why  these attacks were happening were also heavily criticised. The Government was also advised to tread with caution regarding the Syrian War and that any knee jerk reaction must be avoided at all costs. Any decision relating to any form of war should not be based wholly and simply on the recent Paris attacks.

Strakka Racing wants to shine in Sakhir

After qualifying eighth under the floodlights at Bahrain’s stunning Sakhir circuit, Strakka Racing is looking forward to what is set to be a highly competitive final round of the 2015 World Endurance Championship season. After a short delay to the evening’s activities due to a lack of circuit floodlighting, Strakka’s Nick Leventis and Jonny Kane headed out on track to deliver a combined time of 1:52.260 in temperatures that still reached 24°C. With a strong emphasis on tyre management for the race, factoring in how much the track will ‘rubber in’ after more use, the team is confident of being able to race hard in the six hour enduro that sees nine cars taking part this time in the LMP2 class. “It’s been a character building year with a few more setbacks than we could have ever predicted,” says team principal Dan Walmsley. “My biggest disappointment is the on track results don’t reflect the effort and determination shown by everyone in the team, technical partners, suppliers and also, the fans this season. We’ve not given them much to cheer about but through social media and the support they bring to the tracks means we won’t give up until the end of the year. As an example, WEC fans have even cakes baked for us at nearly every round. Thank you for pushing us to do better and work hard for more in 2016.” Tomorrow’s race will start at 3pm local time (12pm UK time) before the team prepares for the Rookie Test when Lewis Williamson and Tio Ellinas will take over the Gibson 015S. Spending time with the team today, Lewis was eager to make the most of his chance to drive an LMP2 car. “It’s my first time here but I’ve been on Strakka’s sim, read all the instructions and listened to the engineers to make sure I make the most of this opportunity.”

Metal Powder Industries Federation Elects McGeehan as President

AMETEK Specialty Metal Products' General Manager to Serve Two-Year Term PRINCETON, NJ – The Metal Powder Industries Federation (MPIF) has elected Patrick J. McGeehan, Vice President and General Manager of AMETEK Specialty Metal Products (SMP), as Federation President.  The two-year term commenced at the conclusion of the federation’s recent annual meeting in Austin, TX. He succeeds outgoing MPIF President Richard Pfingstler of Atlas Pressed Metals, DuBois, Pennsylvania. MPIF, headquartered in Princeton, NJ, is an umbrella trade federation that represents international metal powder producing and consuming industries.  It includes the Metal Powder Producers Association (MPPA), Metal Injection Molding Association, Powder Metallurgy Parts Association, Powder Metallurgy Equipment Association, Refractory Metals Association and Isostatic Pressing Association. Patrick McGeehan’s career in powder metallurgy spans more than 30 years.  He joined AMETEK in 2008 as Vice President and General Manager, Specialty Metal Products. Prior to that, he spent 25 years with Hoeganaes Corporation, mostly recently as Senior Vice President, Operations & Technology. McGeehan has been an active member of MPIF for many years.  He most recently was President of the MPPA and was a member of the MPIF Board of Governors. He was recipient in 2011 of the MPIF Distinguished Service to Powder Metallurgy Award. He also served on the MPIF Technical Board and co-chaired its Roadmap Strategy Board, PM Annual Conference and PM World Congress   AMETEK SMP is a world leader in metal powder, strip, wire, clad and metal matrix composites and holds numerous patents for advanced metallurgical materials.  It is a unit of AMETEK, Inc., a leading global manufacturer of electronic instruments and electric motors with annual sales of more than $4.0 billion.

NCCN Foundation® Appoints Three New Representatives to Board of Directors

FORT WASHINGTON, PA — The NCCN Foundation (http://www.nccn.org/patients/foundation/about.aspx)® has appointed three new representatives to its Board of Directors (http://www.nccn.org/about/leadership.aspx#nccnfoundation): Heather Kopecky, PhD, MBA; Marc Samuels, JD, MPH; and Susan Stein, MPH. There are currently 15 members of the Board of Directors, responsible for the strategic direction for the NCCN Foundation, which obtains funding to publish the library of NCCN Guidelines for Patients (http://www.nccn.org/patients/guidelines/default.aspx)® and the NCCN Quick Guide (http://www.nccn.org/patients/guidelines/default.aspx)™ Series, as well as research grants for young investigators at the National Comprehensive Cancer Network (http://www.nccn.org/)® (NCCN (http://www.nccn.org/)®) Member Institutions (http://www.nccn.org/members/network.asp). “We are honored to welcome Dr. Kopecky, Mr. Samuels, and Ms. Stein to the NCCN Foundation Board of Directors,” said the Honorable Ellen O. Tauscher, Chair of the NCCN Foundation Board of Directors. “These newest members join an esteemed assembly of expert colleagues dedicated to serving people with cancer throughout the United States and the world. Dr. Kopecky, Mr. Samuels, and Ms. Stein indeed will contribute greatly to the leadership of the Foundation.” Dr. Kopecky is a Senior Client Partner at Korn Ferry International where she serves as an industry expert in executive search and coaching, as well as a consultant for prominent academic medical centers, multi-hospital nonprofit health systems, higher education, and professional health care associations. Previously, Dr. Kopecky enjoyed a 20-year career in the Texas Medical Center having had appointments at Baylor College of Medicine, The University of Texas, and Texas Women’s University. Dr. Kopecky is currently a member of the American College of Healthcare Executives, the Healthcare Financial Management Association, the American Organization of Nurse Executives, and the National Association of Corporate Directors. She also serves as a volunteer with the Red Cross Disaster Services Human Resources System. Dr. Kopecky received her Doctor of Philosophy degree in nursing from Texas Women’s University and her Master of Business Administration degree from Rice University. She also holds Master and Bachelor of Science degrees in nursing from The University of Texas Health Sciences Center in Houston, Texas. Mr. Samuels is the Chief Executive Officer of ADVI, an advisory services firm to the lifescience and health care services sectors with end-to-end strategic offerings and a focus on accelerating growth and increasing value. Previously, Mr. Samuels founded HillCo HEALTH and was a partner in HillCo Partners, which merged with Accelus Health Partners to form ADVI in 2013. He has represented the Texas Society of Clinical Oncology, as well as several oncology physician practices and NCCN Member Institutions in Texas and other states; he has co-written many pieces of legislation related to compendia, oral parity, accelerated coverage of biologics, and the Houston Biotechnology Park. Prior to his work at ADVI and HillCo, Mr. Samuels served both former President George Herbert Walker Bush and then-Texas Governor George W. Bush on health care issues in the White House Office of Policy Development and Texas Governor’s Office respectively. Mr. Samuels is a graduate of The University of Texas School of Law, Yale School of Medicine, and the University of Michigan. Ms. Stein is the Founder and Chief Executive Officer of Connexion Healthcare, a communications company focused on translating complex science into clear and concise scientific communication to educate health care providers, support clinical decision-making, and improve patient outcomes. Connexion Healthcare serves the world’s leading biotech and pharmaceutical companies through its two Centers of Excellence – Oncology and Rare Disease. Ms. Stein began her career within the pharmaceutical industry, continuing to the agency side before founding Connexion Healthcare. Ms. Stein also formed Connexion Cares as a vehicle to support health care research and foster patient advocacy. She is a member of the Drexel School of Public Health Dean’s Advisory Council, Member of the Global Genes Board of Directors, and Co-Chair for the Alex’s Lemonade Stand Foundation Lemon Ball. Ms. Stein holds a Master of Public Health degree from Drexel University and a Bachelor of Science degree from University of South Carolina. The NCCN Foundation empowers people through knowledge and advances the mission of NCCN to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. For more information about the NCCN Foundation, visit NCCNFoundation.org (http://www.nccn.org/patients/foundation/default.aspx). ### About the NCCN Foundation Through philanthropy, the NCCN Foundation® empowers people through knowledge and advances the mission of NCCN to improve the quality, effectiveness, and efficiency of cancer care, so that patients can live better lives. About the National Comprehensive Cancer Network The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT. Clinicians, visit NCCN.org (http://www.nccn.org/). Patients and caregivers, visit NCCN.org/patients (http://www.nccn.org/patients).

AZ enters agreement w/ Perrigo for Entocort in US

ASTRAZENECA ENTERS INTO AGREEMENT WITH PERRIGO FOR RIGHTS TO ENTOCORT® IN THE US   Divestment  further sharpens focus on three main therapy areas   Agreement follows ex-US divestment of Entocort in July 2015 AstraZeneca today announced that it has entered into an agreement with Perrigo Company plc for the divestment of US rights to Entocort® (budesonide), a gastroenterology medicine for patients with mild to moderate Crohn's disease, an area of medicine outside AstraZeneca's strategic focus. Under the terms of the agreement, Perrigo will pay AstraZeneca $380 million upon completion of the transaction to acquire the rights to sell Entocort capsules and the authorised generic Entocort capsules marketed by Par Pharmaceuticals. The transaction does not include the transfer of any AstraZeneca employees or facilities. Luke Miels, Executive Vice President, Global Product and Portfolio Strategy, AstraZeneca, said: "Our agreement with Perrigo completes the global divestment of Entocort, emphasising our strategic focus on three main therapy areas and providing further simplification of our supply chain. We are pleased to be working with Perrigo to ensure patients with Crohn's disease in the US continue to benefit from this important medicine." Joseph C. Papa, Chairman, President and CEO, Perrigo, said: "The addition of Entocort represents a strong strategic fit with our portfolio of prescription medicines. It supports our commitment to providing effective, affordable treatments to patients with gastroenterological conditions and we look forward to building on the brand's success in the US market." US product sales of Entocort were $89 million in the year-to-date (at nine months 2015). The transaction is expected to complete by the end of 2015, subject to customary closing conditions. AstraZeneca's 2015 Core Earnings Per Share guidance was upgraded at Year-To-Date & Third Quarter 2015 Results on 5 November and is maintained as it was provided, in the range of mid to high single-digit percentage increase versus the prior year and at constant exchange rates. As AstraZeneca will no longer retain an interest in the US rights to Entocort, the upfront gross receipt will be reported in Other Operating Income in the Company's financial statements. This agreement, along with the agreement (https://www.astrazeneca.com/our-company/media-centre/press-releases/2015/astrazeneca-tillotts-pharma-entocort-gastroenterology-medicine-17072015.html) entered into in July 2015 with Tillotts Pharma AG, part of the Zeria Group, for the divestment of global rights to Entocort outside the US, completes the global divestment of Entocort. About Entocort In capsule formulation, Entocort is a first-line therapy indicated for the induction and maintenance of clinical remission of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. As an enema, Entocort is indicated for the induction and maintenance of clinical remission of distal ulcerative colitis in the rectum, sigmoid colon and descending colon. About Perrigo Perrigo Company plc, a top five global over-the-counter (OTC) consumer goods and pharmaceutical company, offers patients and customers high quality products at affordable prices. From its beginnings in 1887 as a packager of generic home remedies, Perrigo, headquartered in Ireland, has grown to become the world's largest manufacturer of OTC products and supplier of infant formulas for the store brand market. The Company is also a leading provider of generic extended topical prescription products and receives royalties from Multiple Sclerosis drug Tysabri®. Perrigo provides "Quality Affordable Healthcare Products®" across a wide variety of product categories and geographies primarily in North America, Europe, and Australia, as well as other markets, including Israel and China. About AstraZeneca AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology - as well as infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com CONTACTS Media Enquiries   Esra Erkal-Paler  UK/Global +44 20 7604 8030Vanessa Rhodes  UK/Global +44 20 7604 8037Karen Birmingham UK/Global +44 20 7604 8120Jacob Lund  Sweden +46 8 553 260 20Michele Meixell US +1 302 885 2677Investor EnquiriesUKThomas   Kudsk Larsen  Oncology +44   7818 524185Eugenia   Litz RIA +44   7884 735627Nick   Stone CVMD +44   7717 618834Craig   Marks Finance +44   7881 615764Christer   Gruvris  Consensus Forecasts +44 7827 836825USLindsey   Trickett Oncology, ING +1 240 543 7970Mitch   Chan Oncology +1 240 477 3771Dial   / Toll-Free  +1 866 381 7277 Key: RIA - Respiratory, Inflammation and Autoimmunity, CVMD - Cardiovascular and Metabolic Disease,ING - Infection, Neuroscience and Gastrointestinal 23 November 2015 -ENDS-


Destia Group PlcStock Exchange Release 23.11.2015, 9:00 am (CET +1) Destia sells survey, drilling and laboratory services to Mitta Destia Ltd and Mitta Oy have today signed a contract concerning business transaction according to which Destia sells its survey, drilling and laboratory services to Mitta, a Finnish company located in Oulu specialized in land survey, measurement and laser beaming services. Destia will record a capital gain from the transaction, which will have a positive impact on the Group’s operating profit in 2015. The transaction is expected to be completed on 31 December 2015. Due the transaction Destia updates its market guidance for year 2015. The total external revenue of survey, drilling and laboratory services was about 6 million euros in 2014. About 100 employees will move to Mitta as existing employees. ”In line with the business strategy we concentrate on improving our core business and growing in selected business areas. The divestment will clarify our business portfolio and strengthen our balance sheet creating stronger preconditions to develop our core businesses and to grow. Our survey, drilling and laboratory services professionals will strengthen Mitta’s position as a strong domestic expert in the industry. For the personnel this means better development opportunities under new ownership”, says Hannu Leinonen, President and CEO of Destia Group Plc. The Companies have also signed a cooperation agreement concerning survey, drilling and laboratory services which Mitta will provide to Destia in the future. “The acquisition will enhance our ability to serve our customers even more versatile in the whole Finland. The technological development of land and geo survey has been very rapid in recent years and as a leading player in this area in Finland we invest continuously in the development of our personnel, which will further improve our customers' competitiveness”, tells Jari Lappi, CEO of Mitta Oy. DESTIA GROUP PLC Board of Directors More information:Destia Group Plc, President & CEO Hannu Leinonen, tel. +358 20 444 4000Mitta Oy, CEO Jari Lappi, tel. +358 43 2111 600 Distribution:NASDAQ OMX HelsinkiKey mediawww.destia.fi/en Destia:Destia is a Finnish infrastructure and construction service company. We build, maintain and design traffic routes, industrial and traffic environments, as well as complete living environments. Our services cover the whole spectrum, from comprehensive over ground operations to subterranean construction. In 2014 the revenue of the Destia Group was over €430 million. Destia employs about 1,500 people. Mitta:Mitta is a Finnish consultancy company specialized in land survey and measurement, which acts as part of the value chain in construction globally. Mitta is a leading company in the Finnish market, which sectors are survey, laboratory, drilling as well as environmental and energy services. In 2014 the revenue of Mitta was 12.5 million euros. Mitta employs about 125 top professionals.


Destia Group PlcStock Exchange Release 23.11.2015, 9:00 am (CET +1) Destia updates its market guidance for 2015 Destia Group updates its earlier market guidance regarding the operating profit, disclosed in interim report for the third quarter of 2015 on 27 October 2015. On 23 November 2015, Destia and Mitta Oy signed a contract concerning business transaction, according to which Destia relinquishes its survey, drilling and laboratory services to Mitta. The transaction has a positive impact on the Group’s operating profit in 2015. A separate Stock Exchange Release of the sale has been disclosed today. Destia’s revenue in 2015 is forecasted to grow slightly but operating profit is forecasted to fall slightly from the previous year in 2014. Previously Destia estimated that operating profit falls significantly from the previous year in 2015. NEW MARKET GUIDANCE: Destia’s revenue is forecasted to grow slightly and operating profit is forecasted to fall slightly from the previous year in 2015. PREVIOUS MARKET GUIDANCE: Destia’s revenue is forecasted to grow slightly but operating profit is forecasted to fall significantly from the previous year in 2015. Destia will publish its financial statements for 2015 on 11 February 2016. DESTIA GROUP PLC Board of Directors More information:President & CEO Hannu Leinonen, tel. +358 20 444 4000 and CFO Pirkko Salminen, tel. +358 50 302 2485 Distribution:NASDAQ OMX HelsinkiKey mediawww.destia.fi/en Destia:Destia is a Finnish infrastructure and construction service company. We build, maintain and design traffic routes, industrial and traffic environments, as well as complete living environments. Our services cover the whole spectrum, from comprehensive over ground operations to subterranean construction. In 2014 the revenue of the Destia Group was over €430 million. Destia employs about 1,500 people.

Electrolux comments on speculations on settlement

On July 1, 2015, the U.S. Department of Justice (“DOJ”) filed a Complaint in Federal Court seeking to stop Electrolux proposed acquisition of the appliances business of General Electric. Electrolux vigorously contests this effort by the DOJ to oppose the transaction and remains confident in its assessment of the competitive merits of this transaction and its favorable impact on consumers. The review of the proposed acquisition has continued in a court procedure and the trial begun on November 9, 2015. Electrolux expects the trial to conclude in December and anticipates that the Court will reach its decision by late this year or in January 2016, and if resolved favorably, it expects to close the transaction soon after such resolution, following regulatory approvals. Occasionally, disputes like this one are resolved by settlement. While Electrolux may be willing to consider a reasonable settlement with DOJ, Electrolux is currently not in settlement discussions with DOJ. Given the nature of this matter, it cannot be ruled out that settlement discussions may arise or that references to such discussions may be made by counsels of DOJ or Electrolux within the court procedure. As the outcome of any such potential discussions is inherently uncertain, Electrolux does not plan to make any further comments on whether discussions have been or will be initiated, or the status thereof, until it is relevant to provide further updates. 

Ex right to participate in the fully underwritten subsequent repair offering today 23 November 2015

Reference is made to the announcements by Nickel Mountain Group AB (publ.) ("NMG" or the "Company") dated 17 November 2015 and 20 November 2015. The shares in NMG will trade excluding the right to participate in the fully underwritten subsequent repair offering from and including today, 23 November 2015 (ex-date). For and on behalf of Nickel Mountain Group AB Torbjörn Ranta For information, please contact Torbjörn Ranta Mail: torbjorn.ranta@nickelmountain.se Tel: + 46 8 402 28 00 Cell Phone: +46 708 855504 Cautionary Statement: Statements and assumptions made in this document with respect to Nickel Mountain Group AB’s (“NMG”) current plans, estimates, strategies and beliefs, and other statements that are not historical facts, are forward-looking statements about the future performance of NMG. Forward-looking statements include, but are not limited to, those using words such as "may", "might", "seeks", "expects", "anticipates", "estimates", "believes", "projects", "plans", strategy", "forecast" and similar expressions. These statements reflect management's expectations and assumptions in light of currently available information. They are subject to a number of risks and uncertainties, including, but not limited to, (i) changes in the economic, regulatory and political environments in the countries where NMG operates; (ii) changes relating to the geological information available in respect of the various projects undertaken; (iii) NMG’s continued ability to secure enough financing to carry on its operations as a going concern; (iv) the success of its potential joint ventures and alliances, if any; (v) metal prices, particularly as regards nickel. In the light of the many risks and uncertainties surrounding any mineral project at an early stage of its development, the actual results could differ materially from those presented and forecast in this document. NMG assumes no unconditional obligation to immediately update any such statements and/or forecasts.

PA Resources has submitted an application to delist its shares per 31 December 2015

On Friday, 20 November 2015, PA Resources submitted an application to delist its shares from the Nasdaq Stockholm exchange. The application follows the decision by the board of directors to proceed with the delisting as communicated in the press release PA Resources announces its intention to divest its assets and apply for delisting, published on the 17 November 2015. In the application to Nasdaq Stockholm the last date for trading the share has been set to 31 December 2015. PA Resources’ commitment to its creditors to delist its shares was first announced in conjunction with the publication of the Reorganisation Plan on the 9 September 2015. The board of directors deems the 31 December 2015 to be an appropriate date for cessation of trading as by then, sufficient time has passed since the delisting announcement to allow shareholders in PA Resources to sell their shares if they so wish. The last day of trading will, however, ultimately be determined by Nasdaq Stockholm once the application has been processed. Following the delisting the shareholders will retain their shares in PA Resources as an unlisted holding. Stockholm 23 November, 2015PA Resources AB (publ) For additional information, please contact: Petter Hjertstedt, Investor RelationsPhone:   +46 8 545 211 54E-mail:   ir@paresources.se PA Resources AB (publ) is an international oil and gas group which conducts exploration, development and production of oil and gas assets. The Group operates in Tunisia, Republic of Congo (Brazzaville), United Kingdom, Denmark, Netherlands and Germany. PA Resources has oil production in Tunisia. The parent company is located in Stockholm, Sweden. PA Resources’ net sales amounted to SEK 603 million in 2014. The share is listed on the NASDAQ OMX in Stockholm, Sweden. For additional information, please visit www.paresources.se. The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 08:30 CET 23 November 2015.

Data management and backup environment from Proact bring greater efficiency and simple management to Voiceworks

Voiceworks was looking for a new data management and backup solution due to an increase in (customer) data, following the expansion of its portfolio of services.  By entrusting its data management and backup of specific applications to a specialist company, Voiceworks can continue to focus on its core business, i.e. design, development and delivery of innovative communications solutions to its resellers. A key requirement was that the solution had to be easy to integrate into different environments, storage and other platforms, and applications from various producers without needing any additional scripts or adaptations. In addition the complete solution needed to be supported and possibly managed by an experienced partner.  This would enable the ICT staff at Voiceworks to transfer their time and effort to directly supporting applications and projects that benefit the core business. Bas Roos, Technical Operations Manager says, ‘In our search for an enterprise data management and backup solution that could efficiently secure our data, we found the data center and IT infrastructure partner Proact.  We are very impressed by the high degree of knowledge and service at Proact, especially because we have access to Dutch-speaking experts for both advice and support.” The company has chosen a data management solution from Commvault Simpana that can handle several locations, in combination with a Proact backup appliance.  The complete solution is complemented by Proact Premium 24x7 local support, and Professional Services handling implementation. This enterprise data management solution increases the reliability of backup, and data for all (open source) environments can be secured from just one GUI without requiring additional scripts or applications.  This creates a direct increase in efficiency and simple management. With this data management solution Voiceworks can also use modules such as archiving and enterprise search if the business requires and is ready to implement this in its organization. Lucas den Os, Managing Director of Proact in the Netherlands, says, ‘Proact is one of the few CASP (Commvault Authorized Support Partner) partners in Europe that can provide its own support for the Commvault platform.  By combining this with other products and services so that our client can grow gradually depending on their business needs we can offer a single point of contact for our clients.  We are looking forward to cooperating with Voiceworks and hope to continue to advise them on their journey from backup to full data management from a single GUI.’

Crystal Parade Work with X Factor Stylists to Dress Olly Murs’ Dancers

Olly Murs wowed the crowd at last night’s results show on ITV, singing his new track ‘Kiss Me.’ The X Factor stylists called in creative experts Crystal Parade to help dress the 20 dancers taking part in the performance, supplying a range of fabrics and trimmings for the impressive costumes. To celebrate, the embellishment experts are running a competition giveaway in which entrants can win an X Factor goodybag worth £100. It’s not the first time Crystal Parade has been involved in dressing X Factor contestants, as the company formerly supplied thousands of crystals for Leona Lewis’ X Factor appearance in 2013, where she rocked a sparkling crystallised dress. The company has also recently worked with the costume department of the West End show of Kinky Boots. Specialising in Swarovski and Preciosa crystals, feathers, fringing and dance fabrics, the stockists have everything a costume designer or stylist would ever need. Wendy C. Miller, Director of Crystal Parade said, “We’re so excited to have huge TV clients such as The X Factor – it’s great to know that we’re recommended in the showbiz world and as a result we collaborate with celebrities and stylists regularly. Millions of people tune into X Factor every weekend so we’re thrilled our products made an appearance on live TV!”    Olly Murs announced last week that he would be swapping his presenting role for a performing one on the results show on 22nd November. He was hoping to win over fans by returning to his singing roots, following the previous week when he made a live blunder by announcing the eliminated contestant before being handed the envelope with the results. Co-host Caroline Flack defended Olly on Twitter, and later jokingly warned him not to forget his words during the live performance of his new single. Luckily, the performance went without a hitch and Olly’s dancers looked absolutely stunning in their costumes made from Crystal Parade’s materials. The company supplies creative materials and products to global entertainment companies, events companies, film, theatre and TV, as well as independent artists and stylists. For more information about Crystal Parade’s Creative Arts & Corporate services please visit http://www.crystalparade.co.uk/creative-arts Competition Details: Goodybag Details: To give you a little inspiration, we’ve put together a selection of luxury products – perfect for those who love to sparkle! The goodybag has been inspired by Olly’s performance on the X Factor and includes an exclusive selection of crystals, fabrics, feathers and mystery trimmings, worth £100. Giveaway question: Which well-known X factor mega star did Crystal Parade work with in 2013? To be in with a chance of winning the Crystal Parade X Factor goodybag, visit https://www.crystalparade.co.uk/win and answer the competition question.

Nepa grows in Africa by signing The Namibian Broadcasting Corporation (nbc)

The ActionHub™ will enable building integrated multimedia planning, production and publication capabilities across the platforms of the nbc, starting with sport and educational content. The nbc Director General Stanley Similo welcomed the agreement adding that it could not have come at a better time. He said as managers of content on radio and television, the nbc needs to be in the know of its audiences’ preferences. “We are in the business of conceiving and creating programmes for Radio and Television. This task calls for being very conscientious about how we go about in bringing these programmes to life. The latter view is supported by the understanding that whatever is heard or displayed on radio and television, must have been informed by some position that will seek to say: ‘this is what our listeners and viewers want!”. “We will set up the ActionHub™ and start panel recruitment during January of 2016 - with the goal of continually providing the nbc with actionable insights and the voice of its audience in March.” Niat Sebhatu, Global Account Manager at Nepa commented. “This is a milestone for Nepa. We are continuing our aggressive growth strategy on a very exciting continent. We are proud to have The Namibian Broadcasting Corporation (nbc) as a new client and look forward to a fruitful partnership.” Said Olle Råghall, Commercial Director of Media & Entertainment at Nepa.  ABOUT nbc (www.nbc.na) Nbc‘s Purpose is to become a leading Multimedia Public Broadcaster of Choice in the world.  It is the only Namibian broadcasting house that runs radio broadcasting in ten (10) Namibian languages and three (3) Public Service TV channels.  nbc offers local, SADC and international news, current affairs and entertainment programming and covers more than 98% of the Namibian population.  It further broadcasts beyond the Namibian borders on the DSTV audio bouquet and online at www.nbc.na.

Stock Up on Award-Winning Foie Gras – Just in Time for Festive Indulgence

Award-winning retailer, Foie Gras Gourmet, is offering a world-class collection of authentic foie gras, perfect for those that want to indulge over the festive season. It’s easy to obtain the finest foie gras at just a few days’ notice and UK delivery is free with all orders with a 2-day priority service.   Foie Gras Gourmet (http://www.foiegrasgourmet.com/) is the go-to online retailer for those who won’t settle for second best. With Christophe Haton – holder of the prestigious “Meilleur Ouvrier de France” – at the helm, and traditional suppliers dedicated to their craft, the online outlet should be any foie gras lover’s first stop as they stock up on festive indulgences. A spokesman for the brand says, “For people who love exquisite food, foie gras is a special dish, a luxury for special occasions – and what occasion could be more special than the annual celebration of Christmas? If you want to impress someone, foie gras is the go-to offering. Whether giving our exquisite foie gras as a gift, or stocking up for your own enjoyment, our vast selection of award-winning products will provide all the premium foie gras you need this season.” The spokesman adds, “Foie gras is is an extremely rich and luxurious food in terms of texture and flavour, and that is why it is the favourite dish of French people. The French love foie gras because it is absolutely delicious and English people who know the product rapidly become firm fans. Our team at Foie Gras Gourmet headquarters will move heaven and earth to ensure that our UK customers are satisfied with their order.” All products in stock at Foie Gras Gourmet are made in Landes, Périgord in south-western France, where they are prepared traditionally by locals immensely proud of their heritage and skill within the trade. The great value products bear the coveted Label Rouge or PGI (protected geographical indication) seal – giving customers the confidence that they’re buying true quality. Duck and goose foie gras are both available to buy from just £11. The sheer quality of the products available from Foie Gras Gourmet has been proven time and time again, with a range of awards and one ringing endorsement. Espinet, one of the brands available from the site, was served to the Queen of England herself, giving it the royal seal of approval for those who demand only the very best with their Christmas luncheon. Groliere goose foie gras and Pré aux Canards duck foie gras, two of the other brands available from Foie Gras Gourmet, have also been awarded with the coveted 2015 Gold Medal at the Paris General Agricultural Show. UK delivery is free with all orders. The company can provide a multitude of information on foie gras, as well as offering pictures and assistance with articles on the delicacy. For more information, visit the website: https://www.foiegrasgourmet.com Contact: Issued by Dakota Digital. Please direct press queries to Jade Cayton. Email jade@dakotadigital.co.uk or Tel: 01623 428996. 


Leading travel insurer Allianz Global Assistance has launched a contest* giving consumers and bloggers an opportunity to win an all-expenses paid trip to New York to attend The New York Times Travel Show and meet some of the country’s top travel personalities. The VIP Allianz Global Assistance “Concierge” experience will feature a special guided tour of Lower Manhattan and lunch with renowned travel author Pauline Frommer. Winners will also have breakfast with travel personality Mark Murphy and receive expert travel advice over dinner with the “Travel Trifecta” – leading travel bloggers Johnny Jet, Gary Arndt and Lee Abbamonte, keynote speaker at The New York Times Travel Show in 2016 and regular contributor to The Today Show, CNN, FOX Business, FOX News, ABC, CBS and The Travel Channel. The three-night package includes airfare, accommodation at Ink 48 – a Kimpton Hotel, meals with travel personalities, access to The New York Times Travel Show, a travel itinerary curated by Pauline Frommer and a NYC City Pass for VIP admission to iconic New York landmarks including the Empire State Building, Statue of Liberty, and The Metropolitan Museum of Art. Winners will also receive an Allianz Travel Insurance “Go Bag” comprising of a GoPro, Portable Power Pack, Passport Holder with RFID Protection and a personally-signed Frommer’s EasyGuide to New York City. “I’m so excited to take the guide out of the book and onto the streets to connect with my readers on a specially-curated walking tour of lower Manhattan,” said Pauline Frommer, author of Frommer’s EasyGuide to New York City and speaker at The New York Times Travel Show. Travelers can manually enter through a custom Facebook app on the Allianz Travel Insurance USA page (https://www.facebook.com/AllianzTravelInsuranceUS/?sk=app_1650543295215080) to be entered in a drawing to win the trip for themselves and a guest.* For more information on how consumers can enter and to view the complete Official Rules, visit https://www.allianztravelinsurance.com/travel/rules/nyt-show-contest.htm. Bloggers can enter to win by embedding the Allianz “Content Capsule (http://www.travelconfident.us/)” – an easily imbedded microsite with engaging videos, infographics and travel tips, onto their websites. The blogger who drives the most traffic from their readers to the contest entry through the Content Capsule will win the trip for themselves and one guest.*  For more information on how bloggers can enter and to view the complete Official Rules, visit https://business.facebook.com/notes/allianz-travel-insurance-usa/win-a-trip-to-the-new-york-times-travel-show-from-allianz-travel-insurance-offic/1035443479809652. * - Win a Trip to The New York Times Travel Show from Allianz Global Assistance Contest. NO PURCHASE OR PAYMENT NECESSARY TO ENTER OR WIN. A PURCHASE WILL NOT INCREASE YOUR CHANCE OF WINNING. THIS PROMOTION IS NOT INTENDED TO BE AN INDUCEMENT TO PURCHASE INSURANCE. Subject to Official Rules.  Entry starts on November 6, 2015 at 9 a.m. EST and ends on December 4, 2015 at 11:59 p.m. ET. Open to legal residents of the 50 United States and D.C. (except Maine, Utah, and wherever else prohibited by law) who are at least 21 years of age.  For complete Official Rules for the blogger contest, go online to https://business.facebook.com/notes/allianz-travel-insurance-usa/win-a-trip-to-the-new-york-times-travel-show-from-allianz-travel-insurance-offic/1035443479809652. For complete Official Rules for the consumer contest, go online to https://www.allianztravelinsurance.com/travel/rules/nyt-show-contest.htm. Void where prohibited. Sponsor: AGA Service Company d/b/a Allianz Global Assistance, 9950 Mayland Dr., Richmond, VA  23233. # # # Allianz Global Assistance USA Allianz Global Assistance USA (AGA Service Company) is a leading consumer specialty insurance and assistance company.  We insure 18 million customers annually and are best known for our Allianz Travel Insurance plans. In addition to travel insurance, Allianz Global Assistance USA offers tuition insurance, event ticket protection, registration protection for endurance events and unique travel assistance services such as international medical assistance and concierge services. The company also serves as an outsource provider for in-bound call center services and claims administration for health insurers, property and casualty insurers, and credit card companies. To learn more about Allianz Travel Insurance, please visit allianztravelinsurance.com or Like us on Facebook at Facebook.com/AllianzTravelInsuranceUS. Terms, conditions, reductions, and exclusions apply to all plans. All plans not available in all states. For a complete description of the coverage and benefit limits offered under your plan, carefully review your letter of confirmation and certificate of insurance/policy. Insurance coverage is underwritten by BCS Insurance Company (OH, Administrative Office: Oakbrook Terrace, IL), rated “A-“(Excellent) by A.M. Best Co., under BCS Form No. 52.201 series or 52.401 series, or Jefferson Insurance Company (NY, Administrative Office: Richmond, VA), rated “A+” (Superior) by A.M. Best Co., under Jefferson Form No. 101-C series or 101-P series, depending on the insured's state. Allianz Global Assistance and Allianz Travel Insurance are brands of AGA Service Company. AGA Service Company is the licensed producer and administrator of this plan and an affiliate of Jefferson Insurance Company. The insured shall not receive any special benefit or advantage because of the affiliation between AGA Service Company and Jefferson Insurance Company.

Interim Report July 1 - September 30, 2015 Zinzino AB (publ)

”Growth, product launches and a new IT system”Dag Bergheim Pettersen, CEO, Zinzino AB THE PERIOD IN SUMMARYTotal revenues amounts to SEK 101.3 million (87.6), representing a sales growth of 16 % for the Group compared with the year before. Net profits amount to SEK 2.3 million (6.7), equivalent to a profit per share of SEK 0.07 (0.24). The gross profit margin amounts to 30.0% (28.1%), a margin improvement of 1.9 percentiles compared to the year before. THIRD QUARTER, Q3 2015, (compared to the same period in the previous year, 2014) · Total revenues amount to SEK 101.3 million (87.6), representing a growth of 16 %. · EBITDA amounts to 5.3 million (7.0) and the EBITDA margin is 5.3% (8.0%). · Net profit amounted to SEK 2.3 million (6.7). Profit per share amounts to SEK 0.07 (0.24). SIGNIFICANT EVENTS DURING THE PERIOD · Implementation of a new IT system – Zinzino can now face the company's growing sales and globalization. The implementation has been challenging for the business and in the short term during the period negatively affected sales and generated increased costs. Zinzino estimates that the budgeted outcome for the quarter had produced a revenue loss of around SEK 15 million and as a result of this a decline in EBITDA of around SEK 5 million compared with the budget. From a long term perspective the company sees enormous benefits with the investment in the new system and see it as a necessary and important investment for the future. · Start of sales in Canada – initially Zinzino Health was launched on the market, local sales companies were opened with support from the office in the USA. · Product launch – Zinzino LeanShake is a new product within the product line Zinzino Health. A healthy meal substitute for weight control and when exercising. · Product launch – the espresso machine EK´Oh is a new product within the product line Zinzino Coffee. An environmentally-friendly fully-automatically espresso machine. · ”Pick to light” – the logistics provider Katioen Naties has now implemented a picking and packing arrangement ”Pick to light” in the warehouse in Trollhättan, Sweden where Zinzino handles all European orders. This investment leads to further efficiencies and cost rationalization of the handling process for Zinzino. · New improved ZinzinoTest.com has been launched – a new website for Zinzino BalanceTest results that are more informative, easily-managed and more visually appealing. · Faun Pharma AS ISO900 -certification – a quality recognition that opens up new sales channels. The work has also resulted in more efficient production processes and higher end quality of the produced goods. Zinzino expects certification to be completed in Q1 2016. · Faun Pharma AS has at the end of Q3 an order reserve of SEK 14 million, which brings great expectations of a good financial end to 2015 for Faun Pharma AS. · Zinzino is qualified for ”First North Top 25” – one of Nasdaq's 25 biggest and most actively traded company on Nasdaq First North. · The percentage distribution of sales among the product lines during the third quarterIn 2015, 29 % is for Zinzino Coffee and 71 % for Zinzino Health. · Zinzino Health sales amount to SEK 60.7 million (50.3), corresponding to a growth of 21 %. · Zinzino Coffee sales amount to SEK 24.8 million (27.9), representing a fall in sales of 13 %.  COMMENT BY CEO DAG BERGHEIM PETTERSEN: The third quarter was characterized by growth, product launches and new IT system. “During the third quarter of 2015 we have worked all out for our future growth. Major and minor improvements that are not always visible today, but which make a big difference to us in the long term. At the same time, we have managed to increase our growth by 16 percent compared to the same quarter of the previous year and we have good control of profitability. This provides us with accumulated growth, January to September, of 32 percent and an improved gross margin of 3.7 percent compared to the previous year. In other words, we are above our growth forecast of 25 percent. We are pleased with our positive growth and customer flow. Our work for the future during the third quarter can be divided into two categories; product development and new IT system. The development we achieved for our products is very much based on optimizing our manufacturing through a reduction in costs and launching of a number of new product concepts with our own brand within health. This will give us lower production costs and in the long term will strengthen our concept and Zinzino as brand. We have at the same time for a relatively long period worked on and invested in a new IT platform that we launched in August. During the third quarter we worked hard on the implementation. Our new IT system is now in place and we feel confident of having a platform for the future, with a completely new web shop which gives us the ability to follow-up our customers and distributors so that our work becomes more systematic. In the short term this has been challenging for us and not necessarily profitable, but a prerequisite for achieving our long-term goal. We are equipped for new markets and customers and we will with pride and confidence continue our growth with reports and functions what we previously could only dream of. An investment that will give us strength for the future. The quarter's work will means that we meet our ambitious growth target of at least 25 percent during the coming three years and improved profits every year. Our new product concept is a completely new product line that we call weight control. We are proud to have created two new products that go under the name LeanShake. It is a protein shake in which we have used the best ingredients the world has to offer within this segment. We know that the market and interest is great with regard to weight reduction and fitness. We also know that there are plenty of products on the market. We have therefore developed our own product line, that we also manufacture in our own factory. In this way we can with security know that we maintain the highest quality. This is a product segment that we believe strongly in and which will give us continued growth and many new customers during the coming years. During the third quarter Zinzino opened for sales in Canada. The business is run from our office in the USA. During the first quarter of 2016 we plan to open in Germany. Germany and Canada are both major markets which we believe will provide us with strong growth of customers and distributors. We have worked in a cost-effective manner to open new markets through our existing organization, which means that in 2016 we will open more markets and invest even more in existing markets such as the USA and Poland. We have a vision that says that we will inspire lifestyle changes for our customers and distributors. We will do this by being the most customer-friendly direct sales company in the world. We have previously communicated that we have a vision that confirms this. The goal is a million customers in 2020. It's an ambitious target that we believe strongly in and which we will use as a compass in our day-to-day work and that is firmly embedded in our strategy.”Dag Bergheim Pettersen, CEO, Zinzino AB For a full report see attached pdf.This information is such that Zinzino AB is to publish it under the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information will be submitted for publication of November 23, 2015. INFORMATION ABOUT THE COMPANY Zinzino was established under the name of Zinzino Holding in the fall of 2007. During 2009, partly by means of a non-cash issue during the spring and partly through a directed share issue, the company acquired 93 % of the share capital and 97 % of the shares in Zinzino Nordic AB. Zinzino Nordic is a sales company which utilizes independent distributors who market and sell products on commission through what is termed direct selling. NEXT REPORTThe Year-end report for 2015 will be published on February 28, 2016. For further information:Dag Bergheim Pettersen, CEO, Zinzino, phone +47 (0) 93 22 57 00Fredrik Nielsen, CFO, Zinzino, phone +46 (0) 707 900 174Pictures for free publication: Anders Ekhammar, phone +46 (0) 707 462 579www.zinzino.se   Zinzino AB is a leading direct sales company with a presence in Sweden, Norway, Denmark, Finland, Estonia, Latvia, Lithuania, Iceland, the Faroe Islands, Poland, the Netherlands, Canada and the USA. Zinzino markets and sells products within two product lines; Zinzino Health, with a focus on long-term health, and Zinzino Coffee, consisting of espresso machines, coffee, tea and accessories. We offer customers products with a focus on quality, the environment, health and a feeling of everyday luxury . Our values are characterised by our high quality, proximity to customers and focus on active product development. The products are marketed via direct sales. Zinzino owns the Norwegian knowledge company BioActive Foods AS, and the research and production unit Faun Pharma AS. Since 2005 Zinzino has been a general agent for the Franco-Belgian coffee house Rombouts & Malongo. Today Zinzino has around 100 employees in the Group The company has its headquarters in Gothenburg, an office and a factory in the greater Oslo area, an office in Florida, USA and an office in Helsinki, Finland.

Trigon Agri A/S: Invitation to 3Q 2015 results presentation

Trigon Agri will publish its interim report for the third quarter 2015 on Monday, November 30, 2015 at 8:00 CET. Analysts, investors and media are invited to attend a telephone conference that will be held at 10:00 CET on the same day. Program: Joakim Helenius, Chairman of the Board, and Ülo Adamson, President and CEO, will present and comment upon the results. There will also be an opportunity to ask questions. To participate in the telephone conference, please call one of the following numbers: SE: +46 8 505 564 74 UK: +44 203 364 5374 US: +1 855 753 2230 FI: +358 981710460 NO: +47 235 002 10 DK: +45 354 45 580 CH: +41 225 675 541 The presentation material will be available on www.trigonagri.com before the telephone conference starts. A recording of the telephone conference will be available afterwards on www.trigonagri.com. Investor enquiries: Mr. Ülo Adamson, President and CEO of Trigon Agri A/S, Tel: +372 66 79200, E-mail: mail@trigonagri.com About Trigon Agri Trigon Agri is a leading integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri’s shares are traded on the main market of NASDAQ OMX Stockholm. Trigon Agri is managed under a management agreement by Trigon Capital, a leading Central and Eastern European operational management firm with around USD 1 billion of assets under management. For subscription to Company Announcements please contact us: mail@trigonagri.com. If you do not want to receive Trigon Agri press releases automatically in the future please send an e-mail to the following address: unsubscribe@trigonagri.com (mail@trigonagri.com).

Never Be Late for an Appointment Again with Intuitive Alarm Clock App, InTime

Introducing InTime – a game-changing new alarm clock app with the ability to wake you up in time for any meeting, appointment or flight. The intuitive app can take any appointment from your calendar and set your alarm accordingly, taking travel time and other factors into account, to ensure you’ll always arrive right in time – and not a minute later. By analysing your current location, your destination, your planned arrival time, the current traffic levels and any accidents, the app can intuitively set an alarm that will ensure you’ll wake up with plenty of time to spare. With a countdown timer that alerts users when they’ll have to leave home in order to make their appointment, InTime is the next-generation alarm clock for the millennial generation. Jorn munnik, Owner and creator of the inTime InTime (http://www.intimeapp.nl/), says, “Today’s modern professional requires an alarm clock that responds to their needs. Not everyone nowadays wakes up at the same time and makes the same journey to work every day – entrepreneurs, freelancers, consultant, sales people and those doing casual work often have very varied schedules that require an intuitive, adaptable alarm clock.  “That’s where InTime comes in. We wanted to develop an alarm clock that would respond to the demands of the modern user’s life – and we think InTime certainly fits that brief. If you regularly find yourself late for appointments, rushing through security at airports or apologising for showing up late to brunch, InTime is the perfect companion app for your busy lifestyle.” Users can select any appointment from their smartphone calendar, and the app will do all of the legwork. It will calculate what time the user will need to wake up, leaving appropriate time to dress and have breakfast. InTime then sends an alert when the user should be leaving the house, taking into account things like traffic, weather, the time it takes to park the car and the time it might take to walk from the car park to the final destination. InTime also comes with a built-in GPS navigation system link that is pre-filled for the user– so getting lost or being unable to find a certain building is no longer an excuse for the perennially late. Available from the App Store, InTime is totally free to download and use – making it an invaluable resource for modern individuals that need a little help arriving for their appointments on time. For more information, or to download the app today, go to: https://itunes.apple.com/us/app/be-always-on-track-intime./id1013596441?mt=8

ASTRO launches template to help radiation oncologists guide cancer survivors through ongoing care

A new template published by the American Society for Radiation Oncology (ASTRO) standardizes and streamlines the creation of patient-focused plans for long-term cancer survivor care following radiation therapy (RT). As the number of cancer patients and survivors in the U. S. continues to grow – the American Cancer Society predicts a 37 percent increase in the number of cancer patients surviving five years or longer over the next decade – so does the need for greater attention to long-term survivorship care. The template and related research papers, “Development of a Standard Survivorship Care Plan for Radiation Oncologists (http://www.practicalradonc.org/article/S1879-8500(15)00369-0/fulltext)” and “U.S. Radiation Oncology Practice Patterns for Post-Treatment Survivor Care (http://www.practicalradonc.org/article/S1879-8500%2815%2900370-7/fulltext),” are published in Practical Radiation Oncology (PRO), the official clinical journal of ASTRO. The template was developed to coordinate post-treatment care for cancer survivors among the various contributors to their care, including primary care providers (PCPs) and oncology specialists (radiation, medical and surgical), as well as patients themselves. “Factors such as earlier detection of cancer, increasingly effective treatment options, and an aging population lead to a growing number of cancer survivors and, ultimately, a need to educate and empower these individuals for their ongoing care,” said ASTRO chair Bruce D. Minsky, MD, FASTRO. “The ASTRO template is designed to foster better coordination of post-treatment care for cancer survivors, including greater clarity in the dialogue between radiation oncologists and PCPs for issues such as less common side effects that may appear well after treatment is complete.” The framework also enables practices to meet new accreditation requirements set by the American College of Surgeons Commission on Cancer (CoC). In response to a 2006 recommendation from the Institutes of Medicine that cancer patients be provided with a survivorship care plan (SCP) following treatment, CoC issued a mandate that cancer programs provide SCPs for all curative cancer patients by 2019 to maintain accreditation. The new CoC requirement may necessitate changes for the majority of radiation oncology programs, according to data from a March 2014 survey of ASTRO members, which include nearly all practicing radiation oncologists in the U.S. The survey found that only 40 percent and 19 percent of respondents used SCPs for curative and palliative patients, respectively. Primary barriers to implementation included cost and the lack of a standardized, comprehensive SCP framework suited to patients who received RT. Nearly 80 percent of the RT providers that reported using SCPs relied on a framework developed internally within their practice, indicating that different patients may receive different types of information depending on where they receive treatment. “This two-page template facilitates consistency in SCPs across the discipline and also reduces the time and effort required by providers to complete each individual plan,” said Ronald Chen, MD, MPH, an associate professor in radiation oncology at the University of North Carolina at Chapel Hill and lead author on the manuscript that includes the template. “The field of radiation oncology has a long tradition of creating treatment summaries for each patient, even before the Institute of Medicine recommended survivorship care plans in 2006. This radiation-oncology specific template will serve a dual purpose as both a traditional radiation oncology treatment summary and a plan for survivorship care that meets CoC requirements – thus reducing the burden on radiation oncologists from having to create two documents for each patient.” Chen was the chair of ASTRO's Clinical, Translational and Basic Science Advisory Committee, the group that examined current adoption levels of SCPs and developed the template to standardize them in the future. While many radiation oncologists provide their patients with follow-up material such as diagnosis and treatment summaries, contacts for ancillary services such as financial or nutritional counselling, and information on potential late treatment effects, the SCP template coordinates these components in a central, plain language document. The template includes both elements required by CoC in SCPs, namely a summary of past treatment and directions for future care. The treatment summary outlines the survivor’s diagnosis and stage information; treatment details such as the site, dosage and schedule of RT; and contact information for providers who delivered the treatment. The plan for follow-up care covers anticipated toxicities from RT, expected course of recovery from treatment-related toxicities, possible functional and/or social limitations, recommendations for preventative measures and behaviors, cancer information resources, and referrals to supportive care providers.

Audit committee formed in Pandox Aktiebolag (publ)

The audit committee shall, without it affecting the responsibilities and tasks of the board of directors otherwise, monitor Pandox’s financial reporting, monitor the efficiency of the Pandox’s internal controls, internal auditing and risk management, keep informed of the auditing of the annual report and the consolidated accounts, review and monitor the impartiality and independence of the auditors, and assist in the preparation of proposals for the shareholders’ meeting’s decision on election of auditors. FOR MORE INFORMATION, PLEASE CONTACTChristian Ringnes, Chairman of the Board, +47 22 33 05 50 Pandox AB (publ) is required to publish this information under the Swedish Securities Market Act and/or Financial Instruments Trading Act. The information was submitted for publication on 23 November 2015 at 19:45 CET. About PandoxPandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio comprises 104 hotels with approximately 22,000 hotel rooms across eight countries. Pandox’s business is organised into Property management, which comprises hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are, as of 18 June 2015, listed on Nasdaq Stockholm. www.pandox.se

Changes in Duni management team

Meeting customer needs, and thereby growing into the most attractive supplier of table concepts and take-away solutions, is vital for Duni. The aim is to always form the best organization to meet and exceed our customer expectations. Changes will be made in the Duni management team in order to achieve growth in core markets in Central Europe.  Robert Dackeskog, who has a solid HoReCa and international business experience, has been appointed Business Area Director for Table Top. Robert joined Duni in 2012 as Business Area Director Consumer and has since then managed to increase sales as well as profitability for the business area. Maria Wahlgren will leave her position as Business Area Director Table Top and Duni. Tina Andersson, currently Corporate Marketing and Communications Director, will take over the responsibility as Business Area Director Consumer. Tina has a broad experience of marketing, sales and innovation of fast moving consumer goods from international as well as local brands. Tina will retain the responsibility for Corporate Marketing, including branding as well as customer and consumer intelligence. Duni’s CEO Thomas Gustafsson comments: “I am confident that Robert Dackeskog and Tina Andersson will be able to lead the Table Top and Consumer organizations in an efficient as well as visionary way, enabling us to reach our ambitious growth and profitability targets. Maria Wahlgren has been leading the Table Top business area since the reorganization 2012 and since then developed, strengthened and implemented several good initiatives. However, as we have different views on how to manage future challenges, we have come to the mutual agreement that Maria will leave the company and proceed with her career outside of Duni. I wish her the very best in her future career.” For more information, please contact:Thomas Gustafsson, CEO, phone +46 40 106475

Marcus Hedblom appointed new CEO at Ovako

Marcus Hedblom joined Ovako in 2011 as CFO of Ovako. His previous career includes executive positions such as Deputy CFO for SAS Group, CEO at Spanair and a management consulting career at McKinsey. Marcus Hedblom, 45, holds a degree of Master of Science in Industrial Engineering and Management from Linköping University, Sweden. “I am delighted to get the trust to take on this challenge. We have developed a clear strategy based on technological leadership, strong customer focus and operational efficiency. A key effort the coming years is to implement our restructuring program, where the focus lies on increased cost efficiency and productivity. The challenges in an international and very competitive environment are many; I am convinced that Ovako has a very good potential and capability of succeeding", says Marcus Hedblom. “I wish to welcome Marcus Hedblom as President and CEO of Ovako, highlighting his responsibility for the group’s finances through some years of difficult economic development and change. Marcus Hedblom has a broad business background from several industries, a profound interest in building strong customer relationships and handling the challenges of the steel industry in addition to his experience from managing important change programs. Furthermore Marcus Hedblom has strongly contributed to the efficiency increases that we have seen across the Group and has been deeply involved in establishing the restructuring program. Consequently, the change in leadership will give Ovako the continuity that is needed”, says Finn Johnsson, Chairman of the Board. Ovako recently announced a restructuring program. The program affects 300 employees. The annual cost saving for the entire program is estimated to be EUR 45 million, the program is implemented during two years with full effect from 2018. During and after the transition, Ovako will continue to offer all of its current product lines to its customers. The search for a new CFO has been initiated. Press image, Marcus Hedblomhttp://ovakofrontend.qbank.se/detail/1033

MediSapiens Ltd introduces BioIT solution bringing personalized medicine to treatment of cancer patients at the Helsinki University Central Hospital

MediSapiens Ltd (http://medisapiens.com), the leading Finnish bioinformatics software developer, provides the hematology clinic of the Helsinki University Central Hospital with a custom-made software platform that allows taking advantage of biological information to create more effective personalized medical treatment for patients with acute leukemia. The treating physicians can use the platform to analyze genomic data to make more accurate personalized treatment decisions based on how the cancer cells of their patients respond to various drugs. The software is currently in trial use at the clinic, and a larger scale deployment will take place during the year 2016.Behind the platform development is a joint project of the Institute for Molecular Medicine Finland (FIMM), University of Helsinki and Helsinki University Central Hospital. The starting point of the project has been to search for new approaches to treat various cancers through personalized medicine. The project has resulted in developing methods for screening for a variety of individual drug responses using living cancer cells to find the right drug and dosage for each patient. The platform for managing research and patient data helps to make the individual patient’s treatment more effective and to collect unique data which can be used in cancer research and development of new medicinal combinations. ”The new method enables producing large amounts of biological data. Utilizing it in practical every day patient care requires sophisticated data management and correct interpretation”, explains Sami Kilpinen, CEO of MediSapiens. ”The core competence of MediSapiens is in creating custom-made solutions to process complex biological data for research and health care purposes. Genomic information offers unlimited possibilities, of which the development of personalized medicine is an excellent example”, Kilpinen continues. Professor Jonathan Knowles at the Institute for Molecular Medicine Finland (FIMM) considers the development of software solutions enabling individual care an essential part of the evolution of modern medical science. “Personalized care is one of the most important medical advances today and requires solutions to a growing extent. Treatment can be considerably more effective if treatment decisions are based on individual data, and similar methods can certainly also be applied to other types of cancer. When genomic and clinical data are available in unlimited amounts, data management plays a critical role. MediSapiens is in a leading position in creating the necessary tools”, Knowles states. MediSapiens Ltd is a bioinformatics company specialized in pharmaceutical research and translational genomics, providing pharmaceutical and biomedical research organizations with tools that help them design more effective personalized drugs against life-threatening diseases. Established in 2009 and based in Helsinki, Finland and Cambridge, Massachusetts, MediSapiens creates intuitive software platforms to manage, integrate, and visualize complex multi-dimensional datasets, such as genomic sequencing data.  The company's goal is to drive medicine forward by developing tools that provide scientists with a way to quickly analyze and visualize vast amounts of data and turn it into knowledge that fuels innovation. For further information, please visit http://www.medisapiens.com Sami KilpinenCEOEmail: sami.kilpinen@medisapiens.fiPhone: +358458478878 Marie DyhrExecutive assistantEmail: marie.dyhr@medisapiens.fiPhone: +358458478878

SSAB has launched a new www.ssab.com website with an extended product portfolio

SSAB is now including a comprehensive, combined product portfolio on its website. The site has around 2.5 million visits annually and 80% of the visitors are looking for product information. To make the product information easy to find, the new website includes a Steel selector tool to enable product search and comparison. The new site has been planned and optimized in response to customer needs and the content is based on in-depth customer interviews, survey results and user testing. Site usability and functionality have been key elements. Since people are increasingly using mobile devices to browse websites, the new site is responsive to mobile usage. Website information needs to be locally relevant so that customers caneasily search and filter information and find the right salespersons effectively. To answer this need, also country websites in local languages will be rolled out during the next six months.  In addition to product information, corporate sections of the site provide an extensive overview of SSAB as a company to serve target groups, such as the general public, investors, jobseekers and media. The Investors section now contains all share-related matters in one place and uses real-time graphing tools. Newsroom brings together all topical material from different divisions grouped under appropriate tags to help findability. The new web also includes a comprehensive package of sustainability information supporting also SSAB’s vision of a stronger, lighter and more sustainable world. For further information, please contact Kimmo Kanerva, head of digital marketing, +358 20 592 8803

Precise BioMatch Mobile integrated in Xiaomi Redmi Note 3

The integration will generate license revenue starting from the fourth quarter 2015. The value of license revenue is based on the number of sensors FPC delivers to the mobile phone manufacturer and cannot be forecasted at this point. ”Xiaomi is a fast growing company that has become one of three largest Android smartphone brands in the world. We are proud that Xiaomi has chosen Precise BioMatch Mobile in Redmi Note 3. Precise Biometrics fingerprint software is now integrated in products from over 20 vendors and has become the preferred choice to ensure a superior user experience and secure identity verification on mobile devices”, says Håkan Persson, CEO of Precise Biometrics. Precise BioMatch Mobile (http://precisebiometrics.com/fingerprint-technology/precise-biomatch-mobile/) provides easy integration of fingerprint matching functionality for smartphones and tablets, and is optimized for small touch sensors in mobile environments through a unique patented hybrid algorithm. The software offers fast, accurate, and secure verification of the user’s identity, creating a convenient user experience for consumers when unlocking their mobile device or authenticating to services, while delivering enhanced security.Precise Biometrics also offers fingerprint technology to embedded solutions. Precise BioMatch™ Embedded (http://precisebiometrics.com/fingerprint-technology/precise-biomatch-embedded/) provides easy integration of fingerprint matching functionality for numerous environments and applications. This press release contains information that Precise Biometrics is required to disclose pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication at 09.35 am CET on November 24, 2015.

Alfa Laval’s Capital Markets Day - summary of the business update

Service has been a focus area since 2013. The target has been to grow Service in absolute terms and at the same time increase the share of service hours. Looking at the development from 2013 up to now and comparing it to the period 2008-2012, total service growth has gone from a CAGR of 2.6 percent to 7.9 percent. At the same time growth in service operations has gone from 5.3 percent to 9.5 percent. “It is clear that our efforts to increase service operations to both brick wall our installed base and capture growth, has paid off,” said Lars Renström. “We also see continued good growth opportunities going forward, in both the short and medium term“. He also talked about the development of the marine environmentally-related offering, including environmental products, energy-saving products and products dealing with alternative fuels such as natural gas. Total order intake has nearly tripled over the past five years. At the same time the distribution has changed, with products for alternative fuels such as gas showing substantial growth. This is an area that “represents good growth opportunities.” Finally, Lars Renström elaborated on the M&A focus going forward. Given that it is desirable to balance the three divisions, acquisitions are especially interesting to complement the Equipment Division. From a geographical perspective, “we would be very pleased to find something in the US, since we believe the US holds good prospects for the future and we can still increase our market penetration,” Lars Renström said. Thomas Thuresson, Executive Vice President and CFO, gave an update on Alfa Laval’s R&D spend. While the development in absolute terms has steadily increased, as a percentage of sales the trend has actually been slightly downward even if the guidance has remained at 2.5 percent or more. The development, he explained, is due to two main reasons: “firstly a lower R&D spend in most of our acquisitions and secondly, it reflects the activities initiated last fall, to further improve efficiency in R&D.” Against that background “we now change our guidance to 2.0-2.5 percent of sales.” Talking about capital expenditure, the guidance was kept at 2.0 percent of sales, or lower. “However, we have a couple of large projects that started this fall, which will cause some increase to the level you have seen in recent years”, he said. In addition to the regular capex level, up to SEK 200 million will be spent per year in 2016 and 2017. Turning to amortization of step up, the estimate is just below SEK 1.1 billion for 2016, meaning quarterly amortization of approximately SEK 270 million. Furthermore he gave an updated view on the expected FX effects on the adjusted EBITA level. “The forecast has been updated and the positive FX effects are expected to end up at SEK 510 million for this year and at SEK 575 for 2016, Thomas Thuresson said. www.alfalaval.com About Alfa Laval Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling. The company’s equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol. Alfa Laval’s products are also used in power plants, aboard ships, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications. Alfa Laval’s worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena. Alfa Laval is listed on Nasdaq OMX, and, in 2014, posted annual sales of about SEK 35.1 billion (approx. 3.85 billion Euros). The company has about 18 000 employees. www.alfalaval.com For more information contact:Peter TorstenssonSenior Vice President, Communications                                            Alfa LavalPhone: + 6 46 36 72 31Mobile: +46 709 33 72 31                                                                                                                                     Gabriella GrotteInvestor Relations ManagerAlfa LavalPhone: +46 46 36 74 82Mobile: +46 709 78 74 82

J. Tomlinson builds next wave of growth with IFS Applications 9

Founded in the 1950s, J. Tomlinson provide a portfolio of services including construction, refurbishment, repairs and maintenance, mechanical and electrical engineering (M&E), energy efficiency and renewables, fit out and facilities management. Driven by an influx of new contracts, the organisation is enjoying a period of rapid growth with new offices and staff strengthening its business across the UK. To support this growth while helping to manage an increasingly complex IT environment, IFS will provide a complete end-to-end ERP solution that supports 300 employees across multiple locations. IFS Applications will support key business processes for J.Tomlinson such as HR, finance, procurement, planning and scheduling and will include project management and service management modules. To effectively support the company’s mobile workforce, the system will work both offline and online and include touch and mobile applications (http://www.ifsworld.com/en/solutions/ifs-applications/enterprise-mobility/) to support better access to information anywhere, anytime. Once the new solution has been implemented, J. Tomlinson will have the ability to quickly onboard new customers, creating significant time and cost savings per contract. J.Tomlinson Executive Chairman, David Adams, said the single platform will allow his team to focus on meeting the increasingly competitive service level agreements (SLAs) set by its clients, by removing the complexities of managing different systems. “Making working practices and processes more effective will create a more agile organisation for our customers and staff. Crucially, IFS Applications will be a vital component of our future business growth and ongoing customer relationships, providing us with a flexible, sustainable platform that will enable faster, smarter decisions to be made based on real-time information,” he said. IFS UK Managing Director Paul Massey said, “The construction industry is facing increasingly squeezed margins and businesses within the sector need a constant focus on becoming leaner and more innovative. J.Tomlinson is a great example of a company investing in IT to remain competitive and to enable more intelligent business decision making. IFS Applications will improve efficiencies across the organisation, provide visibility into the company’s day-to-day business activities and performance, and help its complete workforce provide a superior customer experience.” The phased implementation will begin with HR, and will go live within the next 12 months. For more information about how IFS helps customers in the construction industry, please visit: http://www.ifsworld.com/en/industries/engineering-construction-infrastructure/

Presentation held at Havbrukskonferansen 2015 24th November 2015

Please find attached the presentation held by Odd Eliasen, Managing Director of Havsbrún, at Havbrukskonferansen 2015 in Oslo today, 24th November 2015. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 23 50 01 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 23 50 60 (mobile) This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. About Bakkafrost: Bakkafrost is the largest salmon farmer in the Faroe Islands. The Group is fully integrated from feed production to smolt, farming, VAP and sales. The Group has production of fishmeal, fish oil and salmon feed in Fuglafjørður. The Group operates licenses on 14 farming fjords. The Group has primary pro­cessing in Klaksvík, Strendur, Kollafjørður, and secondary processing (VAP) in Glyvrar and Fuglafjørður. The headquarter is located in Glyvrar, and the company has a total of around 700 employees. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities. The securities referred to herein may not be offered or sold in the United States absent registration or an exemption from registration as provided in the U.S. Securities Act of 1933, as amended. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada or Japan.

Stena Bulk invests in more IMOIIMAX tankers

The vessels now ordered are of the same type as the ten chemical and product tankers ordered by Stena Bulk in 2012 from the same shipyard, the first four of which were delivered earlier this year. All the IMOIIMAX tankers will be deployed in Stena Weco’s global logistic system, which currently employs more than 60 vessels.http://www.stenaweco.com/ “We are very satisfied with the performance of the IMOIIMAX tankers and are thus adding to this part of our fleet still further. With their greater efficiency as regards fuel consumption and cargo, these vessels are also environmentally superior compared to many other vessels in their class, which, of course, is a major advantage. Commercially, they are a good complement to our fleet”, says Erik Hånell, CEO of Stena Bulk.Four of the ten vessels ordered earlier – the Stena Impression, Stena Image, Stena Imperial and Stena Important – were delivered this year and the remaining six vessels will be delivered by 2017. Of the ten IMOIIMAX tankers, one is wholly owned by Stena Bulk, six are owned together with GAR (Golden Agri Resources), two are owned by the sister company Concordia Maritime and one is wholly owned by Stena Weco.The IMOIIMAX concept is a further development of a well-established and successful concept offering extra high cargo flexibility and even lower fuel consumption. Stena Teknik, together with the shipyard GSI, was responsible for the technical development of the IMOIIMAX concept. The IMOIIMAX tankers have 18 tanks enabling them to transport both vegetable oils and chemicals such as petroleum products.*CSSC OME was formerly GSI (Guangzhou Shipyard International)    For further information, contact:Erik HånellPresident & CEOStena Bulk ABMobile: +46 704 855 002erik.hanell@stenabulk.comWith offices in six countries, Stena Bulk is one of the world’s leading tanker shipping companies. The company controls a combined fleet of around 115 tankers. Stena Bulk is part of the Stena Sphere, which has more than 20,000 employees and sales of SEK 60 billion. www.stenabulk.com

Tobii Pro expands research frontiers with 100 Hz eye-tracking glasses

Stockholm, November 24, 2015 – Tobii Pro (http://www.tobiipro.com/), the global leader in eye-tracking research solutions, extends its line of wearable technology with a new version of Tobii Pro Glasses 2 (http://www.tobiipro.com/product-listing/tobii-pro-glasses-2/). With a frame rate of 100 Hz (images per second), this eye tracker will enable researchers to collect more detailed data for in-depth analysis and real-world insights.     Eye tracking is a powerful and rapidly-growing research method for understanding human behavior. Wearable solutions, where peoples’ eye movements are registered by a pair of eye-tracking glasses, have revolutionized and helped broaden insights with this methodology into a wider range of research fields. Tobii Pro Glasses 2 is ideal for everything from in-store shopper and communication studies, to ethnographic and human performance research. Instead of observing people in artificial lab environments, researchers can study how participants perform tasks in public places, at work or in their homes. This research tool shows exactly what a person is looking at in real time, while they move around freely in any environment. Tobii Pro now doubles the frame rate of Tobii Pro Glasses 2, the world’s smallest, most natural and easy-to-use eye-tracking glasses, by introducing a new 100 Hz version. This new product provides a premium solution for research with more intense requirements when it comes to data granularity and time-based measurements. It gives scientists the unique ability to analyze and accurately report how eye-movement profiles, such as fixations and saccades, vary across different tasks, while capturing the most natural viewing behavior, easily and efficiently. The higher frame rate will be beneficial for a wide range of applications, like measuring cognitive load in driving research, operator assessment, research into visual attention of athletes or reading in natural settings. “I am happy to see sampling frequencies rise for eye-tracking glasses,” said Kenneth Holmqvist, Professor of Psychology at Lund University. “Wearable eye tracking at 100 Hz will give researchers more flexibility for data filtering (noise reduction) or more reliable event detection using velocity-based algorithms. The accelerometer and gyroscope in Tobii Pro Glasses 2 promise to improve event detection during the rotation and translation of the head in real environments.” “More and more researchers want to observe people in their natural surroundings in order to gain deep and precise insights into how they perceive the world around them,” said Tom Englund, president of Tobii Pro. “A prerequisite for capturing authentic behavior in such studies is having research tools that are completely unobtrusive, while at the same time providing the ability to do detailed analysis with high data quality. With the new 100 Hz version of Tobii Pro Glasses 2, we are able to combine all of this into one solution. It means that we take yet another step forward to open up the fields of use for eye tracking in order to benefit more researchers.”Tobii Pro (http://www.tobiipro.com/), part of the Tobii Group, is the leading provider of eye-tracking research solutions and services designed to deepen the understanding of human behavior. Through eye-tracking insights, business and science professionals are enabled to drive change and further their research. The solutions are used in a wide range of fields, from shopper research and usability testing, to psychology and vision research. Tobii Pro has over 2,000 commercial enterprises and 1,500 academic institutions among our clients, including Microsoft, Procter & Gamble, Ipsos, GfK and all of the world's 50 top-rated universities. More information · Read more about Tobii Pro Glasses 2 (http://www.tobiipro.com/product-listing/tobii-pro-glasses-2/) · For sales in the U.S., contact +1-888-898-6244 or sales.us@tobii.com. · For sales in Europe, contact +46 8 52 29 50 04 or sales.an@tobii.com Tobii discloses this information pursuant to the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication on November 24, 2015, at 14:00 p.m. CET. 

Kongsberg Automotive Capital Markets Day 2015

Kongsberg Automotive ASA is pleased to invite to its Capital Markets Day on Wednesday December 2, 2015. The event will take place at Kongsberg Automotive’s offices in Lysaker (Lysaker Torg 35, 0250 Lysaker). 8:45     Registration 9:00     Achievements & strategy for growth            – CEO Hans Peter Havdal 9:30    Automotive market outlook             – SVP IR & M&A Philippe Toth 09:45     Efficient powertrains in the Light Vehicle segment             – VP Sales & Marketing Ian van Duijvenboode   10:15    Break  10:30    Efficient powertrains in the Commercial Vehicle segment             – VP Powertrain & Chassis Espen Moe          11:00    Growing within the Seat Comfort segment             - EVP Interior Systems, Anders Nyström 11:30   Advanced Fluid Handling             - VP Sales & Marketing David Redfearn 12:00     Financial review            – CFO Trond Stabekk 12:20    Summary and closing remarks 12:30    Lunch Our Capital Markets Day is open to the public but for practical reasons we kindly request that you register your attendance by December 1, 2015 via email cmd@ka-group.com or on www.kongsbergautomotive.com. The presentations will be webcasted live on our corporate site from the following link: http://www.kongsbergautomotive.com/investor-relations/webcasts/ (http://www.kongsbergautomotive.com/EPiServer/CMS/Content/investor-relations/webcasts,,3787/?epieditmode=False)

CTT Systems Announces Zonal Drying™ Order for six Boeing 737-800s

“We are pleased with another order for factory installation at Boeing,” said Peter Landquist, VP Sales & Marketing CTT Systems AB. “We are honored that airlines value the benefits from mastering the root-cause of aircraft condensation/moisture problems from the very first day of its entry into service”. The Zonal Drying™ Anti-Condensation System generates the following advantages: ·Lower fuel burn and CO2/NOX emissions from excess weight reduction of 200-300kg of accumulated condensate water in B737/A320 aircraft; ·Higher operational reliability from significant lowered moisture related faults in electrical equipment (reduced Out-Of-Service time) ·Lower attrition of replacing insulation blankets About CTT SYSTEMS CTT Systems is the market leading provider of humidity control products in aircraft, including anti-condensation systems preventing moisture problems in the aircraft and humidifiers for in-flight comfort and wellbeing for crew and passengers. Our products are offered for retrofit installations and line-fit on A380, A350XWB and Boeing 787. The crew humidifier is standard in all crew rest compartment fitted Boeing 787 aircraft and optional in the crew rest compartment on A380 and A350XWB program. The flight deck humidifier is optional on both the Airbus A350XWB and Boeing 787 aircraft. The Airbus A350XWB is first to offer Cair™ humidification as SFE for First/Business Class (Zone1-3). The Zonal Drying™ anti-condensation system is basic equipment in all Boeing 787 aircraft and optional (as Buyer-Furnished-Equipment) on the Boeing 737NG program. The Zonal Drying™ is basic equipment on all Boeing 787 “Dreamliner” aircraft and the humidifiers are standard in all crew rest compartment fitted Dreamliner aircraft and optional for flight deck. The flight deck humidifier is optional on the A350XWB aircraft, the crew rest compartments humidifiers are optional on both A380/A350XWB and the Zonal Drying™ and Cair™ systems are optional on the A350XWB aircraft. Also visit: www.ctt.se   For additional information: Torbjörn Johansson, President, CTT Systems AB.Tel. +46-155-205901 alt. mobile. +46-70-665 24 46, or E-mail: torbjorn.johansson@ctt.se Peter Landquist, VP Sales, Marketing & Customer Support CTT Systems AB.Tel. +46-155-205902 alt. mobile. +46-70-665 24 45, or E-mail peter.landquist@ctt.se This information is disclosed by CTT Systems AB in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements. The information was submitted for publication on November 24, 2015 at 15.45 (CET).

NMG – Increase in share capital related to private placement of 400,000,000 new shares

Reference is made to the stock exchange announcement dated 17 November 2015 regarding the resolution by the extraordinary general meeting of Nickel Mountain Group AB (publ.) ("NMG" or the "Company", ticker "NMG") to increase the share capital in the Company related to the private placement of 400,000,000 new shares (the “Private Placement”). The Company has received confirmation that the share capital increase of SEK 200,000,000 divided into 400,000,000 shares (the “Private Placement Shares”) has been registered by the Swedish Companies Registry. The Private Placement has hence been completed. The new registered share capital of NMG is consequently SEK 245,404,680 divided into 490,809,360 shares, each with a par value of SEK 0.50. In anticipation of publication of a prospectus, and for technical and legal reasons pertaining to system requirements of Euroclear, the VPS and listing of the Private Placement Shares on the Oslo Stock Exchange, the Private Placement Shares will initially be issued in a share class separate from the remaining shares of the Company and registered with Euroclear and the VPS under the International Securities Identification Number ("ISIN") SE0007756929. The Private Placement Shares will carry a voting right at general meetings equal to 99.9% of the voting right attached to each ordinary share in the Company. As soon as practicably possible after the publication of the prospectus, the Private Placement Shares will be converted into ordinary shares of the Company, equal in all respects with the other shares of the Company. As of the same date, the Private Placement Shares will shift ISIN from the aforementioned ISIN to the ISIN of the Company's ordinary shares, ISIN SE0005569100, and be tradable on the Oslo Stock Exchange under the trading symbol of the Company's ordinary shares, "NMG". The Company will issue a stock exchange announcement once the Private Placement Shares are converted into ordinary shares of the Company and are tradable on the Oslo Stock Exchange. For and on behalf of Nickel Mountain Group AB Torbjörn Ranta For information, please contact Torbjörn Ranta Mail: torbjorn.ranta@nickelmountain.se Tel: + 46 8 402 28 00 Cell Phone: +46 708 855504 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act Cautionary Statement: This announcement is not and does not form a part of any offer for sale of securities. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any part of the offering in the United States or to conduct a public offering of securities in the United States. Any offering of the securities referred to in this announcement will be made by means of a prospectus. This announcement is not a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not subscribe for any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus. Statements and assumptions made in this document with respect to Nickel Mountain Group AB’s (“NMG”) current plans, estimates, strategies and beliefs, and other statements that are not historical facts, are forward-looking statements about the future performance of NMG. Forward-looking statements include, but are not limited to, those using words such as "may", "might", "seeks", "expects", "anticipates", "estimates", "believes", "projects", "plans", strategy", "forecast" and similar expressions. These statements reflect management's expectations and assumptions in light of currently available information. They are subject to a number of risks and uncertainties, including, but not limited to, (i) changes in the economic, regulatory and political environments in the countries where NMG operates; (ii) changes relating to the geological information available in respect of the various projects undertaken; (iii) NMG’s continued ability to secure enough financing to carry on its operations as a going concern; (iv) the success of its potential joint ventures and alliances, if any; (v) metal prices, particularly as regards nickel. In the light of the many risks and uncertainties surrounding any mineral project at an early stage of its development, the actual results could differ materially from those presented and forecast in this document. NMG assumes no unconditional obligation to immediately update any such statements and/or forecasts.

Louisiana breast centers invest in Sectra’s Breast Imaging IT solution

Breast Center of Acadiana provides screening mammography along with screening 3D ultrasound to women in southern Louisiana at locations in Lafayette and Youngsville.  The Lafayette location also serves as the referral center for patients requiring more specialized and personalized breast imaging procedures and biopsies for diagnosis of breast cancer and other breast problems.  Gary Mathews M.D., a radiologist who specializes in breast imaging, is the founder and medical director of Breast Center of Acadiana.  “I am eager to implement the Sectra PACS in our practice.  Its versatility and adaptability for customization as well as its worldwide acceptance and proven track record were key factors in my decision. Sectra’s technology will provide a new computer platform to most effectively operate our state of the art imaging including digital mammography, breast ultrasound, automated whole breast (3D) ultrasound, and breast MRI.  With the Sectra system in place, our breast center is better equipped to serve our patients and doctors into the future,” says Dr. Mathews. Sectra PACS displays images from any modality, side-by-side with digital mammograms, facilitating comparison of current and prior images according to radiologist preference. “Sectra’s high quality display and reading flexibility has earned acclaim as the most user-friendly PACS for breast imaging radiologists,” says Mikael Anden, president of Sectra North America.  Sectra Breast Imaging PACS will be showcased in booth #6113 at RSNA in Chicago (http://www.sectra.com/medical/about/campaign/rsna2015/index.html). Illustration: See how Sectra’s solutions are helping care providers to improve cancer care (http://www.sectra.com/rsna/press) Article: Read our article in which experts give their views on the areas in which radiology has the possibility of improving cancer care (http://www.sectra.com/medical/diagnostic_imaging/articles/four_areas_where_radiology_can_improve_cancer_care.html?d)  About Breast Center of Acadiana The Breast Center is dedicated to providing the highest quality service available to the women of Acadiana. A culture has been created within its two locations focusing on personalized care, easing fears and explaining every step in the breast imaging process in a secure atmosphere that caters to the needs of women and their families.  For more information, visit www.breastcenterofacadiana.com

Major League Baseball Players Alumni Association Mourns the Loss of Organization’s Long-Time Board Member Will Royster

Colorado Springs, CO – Major League Baseball Players Alumni Association (MLBPAA), a non-profit organization, mourns the passing of long-time board member and former Major League Baseball player, Will Royster. “Will will be missed and his involvement and his impact in the many MLBPAA activities over the years will not be forgotten, but most of all Will the person will be remembered as one you were fortunate to know,” said MLBPAA Chairman of the Board Jim Hannan. Royster played mainly in the Baltimore Orioles organization throughout his 11-season Major and Minor League career. In 1981, he was selected the Double-A Charlotte Orioles MVP, after setting club records with 31 home runs, 88 RBI and 53 stolen bases. “The Alumni Association lost a good man in Will. He always had a smile on his face and was happy to be part of the team. Will was one of those ‘whatever you need’ guys. I don’t recall ever telling me no – no matter the request,” said Geoff Hixson, MLBPAA Chief Operating Officer. “After he joined the board he was always trying to do more and expand the MLBPAA’s reach. He hosted several events over the years in Atlantic City and was always ready to pack his golf clubs and drive anywhere on the East Coast to help raise funds at our Swing with the Legends golf tournaments. My thoughts and prayers go to his wife and son, a terrific of a golfer who I’m sure will carry on his father’s legacy in the sports world.” Royster was a huge proponent of the MLBPAA’s Legends for Youth Clinic Series, regularly donating his time and expertise at youth clinics across the nation in an effort to inspire and educate youth. He attended multiple fundraising events each year to help raise money for charity as well as enjoy the camaraderie of former players.   About the MLBPAA The Major League Baseball Players Alumni Association (MLBPAA) was formed in 1982 with the mission of promoting the game of baseball, raising money for charity and protecting the dignity of the game through its Alumni players. The MLBPAA is headquartered in Colorado Springs, CO with a membership of more than 7,400, of which approximately 5,600 are Alumni and active players. Alumni Players find the MLBPAA to be a vital tool to become involved in charity and community philanthropy. ###

Notice to attend an Extraordinary General Meeting of Nickel Mountain Group AB (publ)

The Extraordinary General Meeting of Nickel Mountain Group AB (publ), 556227-8043, (the “Company”), will be held on Wednesday, December 23, 2015 at 11.00 pm CET in the premises of the Company at the address Hovslagargatan 5B, bottom floor in Stockholm. Right to attend and notice to the Company Those wishing to attend the meeting must · be entered as a shareholder in the share register kept by Euroclear Sweden AB on Thursday, December 17, 2015, and · give notice of attendance to the Company no later than 4.00 pm CET on Monday, December 21, 2015. Notice of attendance shall be done by regular mail to Nickel Mountain Group AB (publ), Extraordinary  General Meeting 2015, Hovslagargatan 5B, bottom floor, SE-111 48 Stockholm, Sweden, by telephone +46 8 402 28 00, by fax +46 8 402 28 01 or by e-mail to torbjorn.ranta@nickelmountain.se. When giving notice of attendance, please state the shareholder’s name, social security number or corporate registration number, address, and telephone number (office hours). A shareholder may be accompanied by one or two assistants if the shareholders give notice to the Company of the accompanying persons in accordance with what has previously been stated   Shareholding in the name of a nominee To be entitled to participate in the meeting, those whose shares are registered in the name of a nominee must register the shares in their own name with the help of the nominee, so that he or she is entered in the share register kept by Euroclear Sweden AB on Thursday, December 17, 2015. This registration may be made temporarily.    Shareholders registered in the Norwegian Verdipapirsentralen (VPS) must request a temporary entry as shareholders in the share register kept by Euroclear Sweden AB in order to be entitled to participate in the meeting. Shareholders wishing to attend the meeting must notify DNB Bank ASA about this by regular mail to the address Verdipapirservice, Postboks 1600 Sentrum, 0021 Oslo or by e-mail to vote@dnb.no no later than 12.00 noon CET on Tuesday, December 15, 2015, in order for DNB Bank to be able to ensure that an entry is made in the share register kept by Euroclear Sweden AB by Thursday, December 17, 2015, which is the day when such entry must have been executed. Following the meeting, DNB Bank will arrange for the shares to be re-registered in the Norwegian Verdipapirsentralen. Proxies etc. Those who do not attend the meeting in person may exercise his or her rights at the meeting through a proxy in possession of a written proxy form, signed and dated. A template proxy form will be available on the Company’s website www.nickelmountain.se no later than three weeks before the meeting including the day of the meeting. The template proxy form can also be obtained from the Company or can be ordered via telephone in accordance with the above. A proxy form issued by a legal entity must be accompanied by a copy of the certificate of registration or a corresponding document of authority for the legal entity. To facilitate registration at the meeting, proxy forms, certificates of registration and other documents of authority should be submitted to the Company at the address above no later than on Monday, December 21, 2015. Proposed agenda 1. Opening of the meeting 2. Election of chair of the meeting 3. Preparation and approval of voting list 4. Adoption of agenda 5. Election of one or two persons to check the minutes of the meeting 6. Determination of whether the meeting has been duly convened 7. Resolution on change of the Company’s name and amendments to the Articles of Association 8. Resolution on authorization to issue shares and certain other financial instruments 9. Approval of change to the already approved Employee Stock Option Program10. Appointment of new Board of Directors and determination of remuneration to the Board Directors11. Closing of the meeting The proposals by the Board of Directors:  Resolution on change of the Company’s name and amendments to the Articles of Association (item 7) Nickel Mountain Group has in November 2015 changed the business profile from being mainly a mineral exploration company to becoming a debt collection company with focus on Europe. In such way the name Nickel Mountain Group is no longer suitable. The Board of Directors has evaluated various potential names and now proposes a name which has already been approved by the Swedish Companies’ Registrar (Bolagsverket). The proposed name is Axactor AB. The Board of Directors asks the Shareholders’ Meeting to approve the new name and the associated change of the Articles of Association. In view of the proposed agenda item 8, the Board proposes to the Shareholders’ Meeting to change the limits of the share capital and of the number of shares stipulated in the Articles of Association. The limits of the share capital are proposed to be a minimum of SEK 200 million and a maximum of SEK 800 million. This implies that the minimum number of shares outstanding shall be 400 million and the maximum amount of shares outstanding shall be 1,600 million. Resolution on authorization to issue shares and certain other financial instruments (item 8) The Board of Directors proposes that the general meeting resolves to authorize the Board of Directors to, on one or more occasions before the Annual General Meeting of 2016, resolve on issues of shares, warrants and/or convertible instruments, mainly in accordance with the following.  Issues may be carried out with or without considering the shareholders’ preferential rights.  The total number of shares which can be issued through resolutions under the authorization  shall not exceed 280,000,000 shares through share issues, the exercise of warrants and/or conversion of convertible instruments (this does, however, not prevent warrants and convertible instruments from being combined with terms and conditions for recalculation which, if applied, may result in another number of shares), corresponding to approximately 30 percent of the number of shares and votes in the Company after completion of the  issues approved at the Extraordinary General Meeting on November 17, 2015. Issues carried out without the shareholders’ preferential rights with cash payment or payment by set-off of claims, may only take place at a price in line with the market price of the Company’s share with a deduction for such market-related discount deemed required by the Board of Directors for successfully carrying out the issue. In case of a rights issue, the Board of Directors decides on the pricing. The authorization shall include a right to resolve on issues with cash payment, payment by set-off of claims or payment with non-cash consideration, and in combination with such conditions referred to in Chapter 2, section 5 second paragraph, points 2–3 and 5 of the Swedish Companies Act.  The reason for the Board of Directors’ proposal as well as the possibility to disregard the shareholders’ preferential rights is that the Company must be prepared to without delay improve its financial position and strengthen the shareholder value by way of opportunities that may arise. This authorization replaces the authorization approved at the Annual General Meeting on June 3, 2015. Resolution on change to the conditions of the Employee Stock Option Program (item 9) At the Extraordinary General Meeting held on November 17, 2015 the shareholders decided to implement an Employee Stock Option Program. In the resolution taken in this regard the conditions stipulated that the first tranche of options would be exercisable 12 months after the issue date. The Board now proposes to the EGM on December 23, 2015 to change said conditions so that the Board of Directors gets an authorization to push forward the exercise date of the first tranche options to 24 months after the date of issue. Appointment of new Board of Directors and determination of remuneration to the Board Directors (item 10) In view of the Company’s new business direction and the increased financial resources, it has been deemed both suitable and necessary to change the composition of the Board of Directors. The previous Nomination Committee of the Company resigned at the Annual General Meeting on June 3, 2015. It has not yet been replaced by a new committee. The process to appoint such new Nomination Committee is however ongoing.  The ambition is that a proposal for a new Board of Directors and for remuneration to the Directors shall be published as soon as practically possible, latest in connection with the Extraordinary General Meeting. Documents The Board’s complete proposals to items 7 - 9 will be available at office of the Company and on the Company’s website www.nickelmountain.se. Copies of the proposals as well as other required documents will be sent free of charge to those shareholders who so request and state their postal address. Shareholders’ right to request information Shareholders are reminded of their right to obtain information from the Board of Directors and from the Managing Director in accordance with Swedish Companies’ Act § 7:32. Shares and votes As per the day of this notice, the total number of shares and votes in the Company is 90,809,360, however a registration matter of 400 million new shares has been submitted to the Swedish Companies’ Registrar.  ____________________________ Stockholm, November 2015 Nickel Mountain Group AB (publ) The Board of Directors

Karolinska University Hospital to purchase Elekta’s Leksell Gamma Knife Icon

STOCKHOLM, November 25, 2015 – By acquiring Elekta’s (EKTA-B.ST) latest generation intracranial stereotactic radiosurgery system, Leksell Gamma Knife® Icon™, Stockholm’s Karolinska University Hospital will be able to offer the benefits of precision cranial radiosurgery to more patients with a wider variety of tumor types and sizes. The hospital was instrumental in the history of radiosurgery as Lars Leksell, Elekta’s founder, received his medical degree at Karolinska Institutet, then went on to develop the original Leksell Gamma Knife® system while serving as a professor of neurosurgery there. Gamma Knife Icon is the sixth generation of the company’s Leksell Gamma Knife system, a technology that has been in use worldwide and continually evolving since the 1980s. With stereotactic imaging, online Adaptive DoseControl™, ultra-precise dose delivery and the availability of frameless treatments, Icon is capable of treating virtually any target in the brain, regardless of type, location or volume. Tomas Puusepp, Elekta’s President and CEO, says: “We are happy that Karolinska University Hospital has chosen the most advanced Leksell Gamma Knife radiosurgery system when they open the doors to their new hospital, New Karolinska Solna. We hope to continue working with Karolinska to provide them with the best solutions available as they strive to improve patient care.” For more information on Leksell Gamma Knife Icon, visit www.careforthebrain.com # # # For further information, please contact:Gert van Santen, Group Vice President Corporate Communications, Elekta ABTel: +31 653 561 242, e-mail: gert.vansanten@elekta.comTime zone: CET: Central European Time Johan Andersson, Director, Investor Relations, Elekta ABTel: +46 702 100 451, e-mail: johan.andersson@elekta.comTime zone: CET: Central European TimeThe above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on November 25, 2015. About ElektaElekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com

RaySearch Laboratories AB (publ) interim report January 1 – September 30, 2015

NINE MONTHS (JANUARY-SEPTEMBER, 2015) · Net sales for the period amounted to SEK 265.6 M (177.4), of which RayStation® accounted for SEK 190.9 M (104.2) · Profit after tax totaled SEK 36.9 M (19.1) and earnings per share were SEK 1.08 (0.56) · Operating profit amounted to SEK 51.0 M (26.6) · Cash flow was a negative SEK 8.8 M (neg: 14.0) · Order intake excluding service agreements amounted to SEK 267.3 M (144.4), of which RayStation® accounted for SEK 214.0 M (88.5) THIRD QUARTER (JULY-SEPTEMBER, 2015) · Net sales for the period amounted to SEK 100.6 M (71.6), of which RayStation® accounted for SEK 73.9 M (52.3) · Profit after tax totaled SEK 14.5 M (13.2) and earnings per share were SEK 0.42 (0.39) · Operating profit amounted to SEK 20.1 M (18.2) · Cash flow was a negative SEK 6.5 M (neg: 2.7) · Order intake excluding service agreements amounted to SEK 109.0 M (42.8), of which RayStation® accounted for SEK 89.6 M (29.4) · RayStation® order backlog totaled SEK 58.2 M (44.8) at the end of the period SIGNIFICANT EVENTS DURING THE THIRD QUARTER · RaySearch secured a number of major orders from some of the world’s largest and most respected cancer clinics, including the University of Texas MD Anderson Cancer Center and the University of Florida Health Proton Therapy Institute in the US, as well as Gustave Roussy in France · Long-term collaboration agreements were signed with Accuray regarding the RayCare® Oncology Information System, and treatment planning support for the TomoTherapy® and CyberKnife® systems in RaySearch’s treatment planning system, RayStation® SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD · Anders Liander, CTO, decided to leave the company in November to pursue his own interests ABOUT RAYSEARCHRaySearch Laboratories AB (publ) is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on Nasdaq Stockholm. More information about RaySearch is available at www.raysearchlabs.com. FOR FURTHER INFORMATION, PLEASE CONTACT: Johan Löf, President and CEOTel: +46 8 510 530 00johan.lof@raysearchlabs.com

Eltel wins two major power transmission contracts in Poland at a value of approximately EUR 26 million

The contract for the overhead transmission line is a turnkey project is to build a double circuit 400 kV line from the Pasikurowice substation to Czarna substation. The total length of the line is approximately 60 kilometres. In addition to the construction of the new line, the contract includes dismantling of an existing overhead line and modernization of the optical fibre truck between Pasikurowice and Czarna substations. Eltel is the leader of the consortium with Elfeko Gdynia Co as its partner. The total value of this contract is EUR 40 million of which Eltel’s share is approximately EUR 20 million. The project is expected to start in the first quarter of 2016 and is estimated to be delivered in the second quarter of 2021. The new line will secure power supplies to consumers in the south-western part of Poland. The second contract is a turnkey project at Czerwonak for a reconstruction and upgrading of an existing 220/110 kV substation to a 400 kV level. The value of this contract is approximately EUR 6 million. The project is estimated to be completed in March 2017. Axel Hjärne, CEO of Eltel comments:“Winning of these contracts further strengthens Eltel’s position in the Polish power transmission market, both in overhead lines and substations. We are happy to continue the development of the Polish transmission system in collaboration with PSE S.A.”. For further information:Ingela UlfvesVP - Investor Relations and CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com Hannu TynkkynenSVP - Group CommunicationsTel: +358 40 311 4503, hannu.tynkkynen@eltelnetworks.com About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. The current number of employees is approximately 9 300. In 2014 Eltel’s net sales amounted to EUR 1 242 million. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

H&M Conscious Exclusive 2016 - Historic art inspires fashion for the future

"I am honoured to be the ambassador of such a unique project. I think that the idea of creating a collection inspired by the history of art and fashion is fantastic. Especially since it is made with innovative and sustainable materials which are the future of fashion" says Julia. Known for her distinctive, personal sense of style, Julia is the embodiment of effortless, conscious and modern cool. For this Conscious Exclusive collection the H&M design team has worked closely with the museum, delving into their collections of archival fashions as well as the work of artists such as Gustave Moreau to find inspiration. The outcome is a glamorous line of modern red carpet pieces infused with tactile charm, a nostalgic aesthetic and a historical legacy. "With this collection we brought the idea of sustainability to new levels. Working with new innovative materials such as beads and rhinestones made from recycled glass and Denimite, a material made from recycled worn-out denim. We have created contemporary styles imbued with a sophisticated charm" says Ann-Sofie Johansson, Creative Advisor at H&M. H&M will be the exclusive sponsor of the upcoming exhibition which will include selected styles from the H&M archives, including a look from the first ever H&M designer collaboration with Karl Lagerfeld in 2004 as well as one silhouette from the new Conscious Exclusive collection. The complete collection, featuring clothing and accessories for women, will be available from Thursday 7th April in around 180 stores worldwide and online at hm.com (http://www.hm.com/entrance.ahtml).

Saab Provides Service Life Extension For RBS 97 Air Defence System

The RBS 97 (Hawk) is a surface-to-air missile system that is part of Sweden’s national defences. It is capable of shooting down high-flying targets, in all weather conditions, at a range of up to 40 km. The service life extension will implement new capabilities for the system, making it better able to counter current and future airborne threats. The work will include upgrades to hardware and software across all system components such as the high power illuminating radar, missile launcher and combat command unit. This new order, combined with other existing, similar business, will require Saab’s Växjö facility to recruit more staff with the relevant hardware and software engineering expertise. The possibility of transferring personnel from Sweden’s Air Defence Regiment for a limited time is also being explored, within the cooperative framework for skills development that exists between Saab and the Swedish armed forces. "This order provides Saab with an opportunity to expand and puts us in a good position to support the customer when the time comes to replace the RBS 97 missile system," says Joakim Haux, head of Weaponry Services, business unit Land within Saab´s business area Support and Services. The service life extension will be conducted on a staged basis from now until 2019. Saab will undertake the majority of the work in Växjö, but also in Halmstad and Järfälla. For further information, please contact: Saab Press Centre, +46 (0)734 180 018, presscentre@saabgroup.com www.saabgroup.com www.saabgroup.com/YouTube Follow us on twitter: @saab Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Capital Markets Day and financial ambitions towards 2018

DNB is hosting its Capital Markets Day in London today. DNB’s key financial ambitions for 2016 - 2018 are: Return on equity (ROE): Above 12% CET1 capital ratio: Minimum 15% as capital level (CET1) as at 31 December 2016 Dividend ambitions: 2015: around 30%, 2016: 30-50% and 2017: >50% Cost/income ratio: Below 40% towards 2018 Other ambitions are covered in the attached presentations. DNB will reach the capital requirement of 15 per cent through strong retained earnings and capital efficiency measures. The capital efficiency measures expect to have a total effect of 80–120 bps from end Q3 2015 to Q4 2016 and include asset disposal/reallocation and financial restructuring. DNB’s capital target for 2017 is about 15.5% and includes a management buffer of approximately 50 bps. For more information: Rune Helland, head of Investor Relations, mobile (+47) 977 13 250 Thomas Midteide, group EVP, Corporate Communications, mobile (+47) 962 32 017 The presentations from the event are attached below or available on www.dnb.no/ir See the presentation from the CMD on Web-TV from your desktop PC here (http://presenter.qbrick.com/?pguid=7b64f3bd-207e-4c5c-b299-9047d7b9a967) from 12.30 GMT / 13.30 CET or if problems with link go to https://www.dnb.no/en/about-us/investor-realtions/capitalmarketday2015.html or www.dnb.no/ir See the presentation from the CMD on Web-TV from your mobile device / tablet here (http://publisher.qbrick.com/Embed.aspx?mcid=0C944083a74108a6&width=640&height=360) from 12.30 GMT / 13.30 CET or if problems go to https://www.dnb.no/en/about-us/investor-realtions/capitalmarketday2015.html or: m.dnb.no

Interim financial report for the 9-month period January 1 – September 30, 2015 and for the quarter July – September 2015 (Q3)

Major events after end of the report period · On October 16, 2015 NMG published that it had, subject to shareholder approval,  entered in to a conditional purchase agreement relating to leading Spanish private debt collection company, ALD Abogados S.L. (“ALD”) for a total consideration of some 18 million Euro whereof some 5 million Euro in kind via some 47 million NMG-shares to be issued. In this conjunction NMG also announced a fully underwritten directed issue of 400 million shares at an issue price of 1 NOK per share. And in the same context a rights issue of up to 60 million new shares was announced at the same issue price, also fully underwritten.  In essence, NMG has in accordance with previously published intentions embarked on a new growth strategy as international debt collection company, and the mineral assets may be disposed of in due time. An Extraordinary Shareholders’ Meeting held on November 17 approved of the proposed acquisition of ALD and the associated share issues. Following the mentioned EGM, a new company management with Mr. Endre Rangnes as new CEO was appointed.  In early October NMG also notified the stock market that the Swedish tax authorities have asked for additional information in respect of the tax declaration for fiscal year 2013 for one of NMG group’s subsidiaries at that time. · On November 25, 2015 NMG convened an EGM for December 23 in Stockholm, where inter alia a new company name and a new Board of Directors will be proposed. Financial results for the nine-month period January – September 2015 and for the quarter July - September 2015 · The net result after tax for the 9-month period January – September 2015 amounted to MSEK –89.9 (MSEK –7.0 excluding and MSEK -11.8 including discontinued operations). This corresponds to earnings per share (EPS) of SEK –0.99 (SEK –0.32 excluding discontinued operations and SEK -0.55 including discontinued operations).  · The total comprehensive result for the first nine months of 2015 was MSEK –89.9 (MSEK –12.9). · The net result after tax for the last quarter July - September 2015 amounted to MSEK –4.8 (MSEK –1.6). This corresponds to EPS of SEK –0.05 (SEK –0.07 excluding and including discontinued operations). · The total comprehensive result for the third quarter of 2015 was MSEK –4.8 (MSEK -1.6).

Kickstarter Project Aims to Create the Next Leap in Communication with Heartbeat Device

The holiday season can be particularly difficult for couples in long distance relationships or people separated from family members. Now, thanks to a clever wearable device and smartphone app designed by Little Riot launched on Kickstarter, lonely hearts can drift off to the sound of their loved one’s heartbeat. Pillow Talk is an innovative product that transmits the sound of one person’s heartbeat to another’s pillow, using two beautifully-designed wristbands, speakers and a smartphone app. The idea is a labour of love for 28-year-old designer and entrepreneur Joanna Montgomery, and has received interest from long-distance lovers around the world. Having launched on Kickstarter two weeks ago, the project is now over 50% funded and Little Riot are conducting one last promotional push to reach the £75,000 target. Improvements in technology mean that separated families can now communicate more easily, and even see the faces of their loved ones on video calls. Pillow Talk aims to take the next big leap for communication, creating a connection that families can feel, not just see or hear. “Pillow Talk is about feeling that physical connection with someone”, says Jo. “Anyone who has spent time apart from someone they love knows that - while it’s great to talk to them on something like Skype - you don’t get that same closeness from a face on a screen. We designed Pillow Talk to give people that feeling that they’re somehow closer together, even when they’re many miles apart.” Little Riot has designed Pillow Talk to be used by lovers and families, regardless of how far apart they are. The wristband picks up the user’s heartbeat and uses a smartphone app to transmit it to a receiver in their loved one’s pillow. The device then transmits the sound and pace of the heartbeat, a soothing rhythm that provides loved ones with a far more intimate connection than just email or calls. Joanna first came up with the idea for Pillow Talk while studying at university. Her first video showcasing the concept struck a chord with separated families around the world, and she quickly built up a waiting list of over 50,000 people, many of which have family members serving in the military. She has since been fine-tuning the technology with the help of the Wayra UK startup accelerator, which is funded by Telefonica. Pillow Talk has many benefits for both parties – it can soothe and create conditions for better sleep as a beating heart is a relaxing sound. The ongoing connection also provides a sense of security, as however far apart one person may be from the other, both users know the other person is in bed, safe and well and possibly dreaming of one another. Backers can reserve their Pillow Talk set or secure other rewards by pledging to the Kickstarter campaign at https://www.kickstarter.com/projects/littleriot/pillow-talk-feel-the-presence-of-your-loved-one